<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101573691</journal-id><journal-id journal-id-type="pubmed-jr-id">39703</journal-id><journal-id journal-id-type="nlm-ta">Cell Rep</journal-id><journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id><journal-title-group><journal-title>Cell reports</journal-title></journal-title-group><issn pub-type="epub">2211-1247</issn></journal-meta><article-meta><article-id pub-id-type="pmid">30157433</article-id><article-id pub-id-type="pmc">6298213</article-id><article-id pub-id-type="doi">10.1016/j.celrep.2018.07.101</article-id><article-id pub-id-type="manuscript">NIHMS1505951</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mitochondrial Complex I Activity Is Required for Maximal
Autophagy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>Hala Elnakat</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stefely</surname><given-names>Jonathan A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Veiga</surname><given-names>Sonia R.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>George</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kozma</surname><given-names>Sara C.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mercer</surname><given-names>Carol A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A5">5</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Hematology/Oncology, University of Cincinnati,
Cincinnati, OH, USA</aff><aff id="A2"><label>2</label>Medical Scientist Training Program, School of Medicine and
Public Health, University of Wisconsin-Madison, Madison, WI, USA</aff><aff id="A3"><label>3</label>Laboratory of Metabolism and Cancer, Catalan Institute of
Oncology, ICO, Bellvitge Biomedical Research Institute, IDIBELL, 08908 Barcelona,
Spain</aff><aff id="A4"><label>4</label>Unit de Biochemistry, Department of Physiological Sciences
II, Faculty of Medicine, Campus Universitari de Bellvitge-IDIBELL, University of
Barcelona, 08908 L&#x02019;Hospitalet de Llobregat, Barcelona, Catalonia, Spain</aff><aff id="A5"><label>5</label>Lead Contact</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">AUTHOR CONTRIBUTIONS</p><p id="P2">C.A.M., H.E.T., J.A.S., S.C.K., S.R.V., and G.T. conceived and
designed the experiments; C.A.M., Y.Z., H.E.T., and J.A.S. performed the
experiments; C.A.M. directed the studies; and C.A.M., H.E.T., Y.Z., J.A.S.,
S.R.V., S.C.K., and G.T. contributed to the writing of the manuscript.</p></fn><corresp id="CR1"><label>*</label>Correspondence:
<email>mercerc@ucmail.uc.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>7</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="ppub"><day>28</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>12</month><year>2018</year></pub-date><volume>24</volume><issue>9</issue><fpage>2404</fpage><lpage>2417.e8</lpage><!--elocation-id from pubmed: 10.1016/j.celrep.2018.07.101--><permissions><license><license-p>This is an open access article under the CC BY-NC-ND license
(<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><abstract id="ABS1"><title>SUMMARY</title><p id="P3">Cells adapt to nutrient and energy deprivation by inducing autophagy,
which is regulated by the mammalian target of rapamycin (mTOR) and AMPactivated
protein kinases (AMPKs). We found that cell metabolism significantly influences
the ability to induce autophagy, with mitochondrial complex I function being an
important factor in the initiation, amplitude, and duration of the response. We
show that phenformin or genetic defects in complex I suppressed autophagy
induced by mTOR inhibitors, whereas autophagy was enhanced by strategies that
increased mitochondrial metabolism. We report that mTOR inhibitors significantly
increased select phospholipids and mitochondrial-associated membranes (MAMs) in
a complex I-dependent manner. We attribute the complex I autophagy defect to the
inability to increase MAMs, limiting phosphatidylserine decarboxylase (PISD)
activity and mitochondrial phosphatidylethanolamine (mtPE), which support
autophagy. Our data reveal the dynamic and metabolic regulation of
autophagy.</p></abstract><abstract id="ABS2" abstract-type="summary"><title>In Brief</title><p id="P4">Autophagy is a survival response to starvation conditions, which inhibit
the mTOR kinase. Thomas et al. demonstrate that autophagy induced by mTOR
inhibitors is limited by phenformin and defects in OXPHOS but enhanced by
strategies that increase mitochondrial energy and phospholipid metabolism. The
therapeutic relevance of these findings is discussed.</p></abstract><abstract id="ABS3" abstract-type="graphical"><title>Graphical Abstract</title><p id="P5"><graphic xlink:href="nihms-1505951-f0001.jpg" position="anchor" orientation="portrait"/></p></abstract></article-meta></front><body><sec id="S1"><title>INTRODUCTION</title><p id="P6">Autophagy targets long-lived proteins, complex molecular structures, and
organelles for lysosomal degradation, maintaining homeostasis under basal conditions
and generating molecular building blocks to support essential cellular processes
during starvation. The term autophagy in the broadest sense includes macroautophagy,
microautophagy, and chaperone-mediated autophagy (<xref rid="R92" ref-type="bibr">Yang and Klionsky, 2010</xref>). The multistep process of macroautophagy, which
we will call autophagy, responds to signals that trigger (1) the formation of
double-membrane autophagosomes to sequester cargo, (2) trafficking along
microtubules, (3) fusion with the lytic compartment, and (4) enzymatic degradation
of contents to be released and recycled. Autophagy is thus a catabolic process to
supply metabolites for anabolic processes. However, autophagy is anabolic in that it
requires the continued biosynthesis of autophagosomes, involving the coordinate
regulation of autophagy proteins, lipids, and sufficient energy at localized regions
of assembly (<xref rid="R35" ref-type="bibr">Kaur and Debnath, 2015</xref>; <xref rid="R92" ref-type="bibr">Yang and Klionsky, 2010</xref>). It is now recognized
that autophagy, initially thought to be nonselective in the sequestration of cargo,
is often selective, using adaptors or receptors to link specific cargo such as
mitochondria to the growing autophagosome (<xref rid="R19" ref-type="bibr">Farr&#x000e9; and Subramani, 2016</xref>).</p><p id="P7">Autophagy is regulated by three interrelated protein kinases: the mammalian
target of rapamycin (mTOR), Unc-51-like kinase 1 (ULK1), and AMP-activated protein
kinase (AMPK) (reviewed by <xref rid="R69" ref-type="bibr">Russell et al.,
2014</xref>). mTOR&#x02019;s role in autophagy was established more than 20 years
ago and is conserved from yeast to mammals. Specifically, TOR in yeast inhibits the
activity of the autophagy-related 1 kinase (Atg1), similar to mTOR&#x02019;s
inhibition of ULK1, albeit with mechanistic differences (reviewed in <xref rid="R55" ref-type="bibr">Noda, 2017</xref>). Autophagy is induced by starvation and
rapamycin, inhibitors of mTOR complex (mTORC) 1 (<xref rid="R92" ref-type="bibr">Yang and Klionsky, 2010</xref>), and by next-generation mTOR kinase inhibitors,
which are more potent inhibitors of mTORC1 and mTORC2 (<xref rid="R80" ref-type="bibr">Thomas et al., 2012</xref>). However, it is possible to inhibit
mTORC1 without activating autophagy; for example, both mTORC1 and autophagy are
inhibited by lysosome inhibitors (<xref rid="R1" ref-type="bibr">Amaravadi et al.,
2011</xref>; <xref rid="R98" ref-type="bibr">Zoncu et al., 2011</xref>).</p><p id="P8">An understanding of AMPK&#x02019;s role in autophagy was complicated by early
reports that the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleotide
(AICAR) inhibited autophagy (<xref rid="R70" ref-type="bibr">Samari and Seglen,
1998</xref>), which was later found to be independent of its effects on AMPK
(<xref rid="R46" ref-type="bibr">Meley et al., 2006</xref>). Reports that energy
deprivation and subsequent activation of AMPK were sufficient, if not required, to
inhibit mTOR (<xref rid="R23" ref-type="bibr">Gwinn et al., 2008</xref>; <xref rid="R28" ref-type="bibr">Inoki et al., 2003</xref>; <xref rid="R33" ref-type="bibr">Kalender et al., 2010</xref>) suggested that AMPK induced
autophagy through inhibition of mTOR. A more direct role was established when AMPK
was shown to phosphorylate ULK1 (<xref rid="R18" ref-type="bibr">Egan et al.,
2011</xref>; <xref rid="R36" ref-type="bibr">Kim et al., 2011</xref>). The
latter studies used multiple tools, including AICAR, to activate AMPK and define
ULK1 phosphorylation sites, although AICAR, as mentioned earlier, does not induce
autophagy (<xref rid="R70" ref-type="bibr">Samari and Seglen, 1998</xref>).</p><p id="P9">There are conflicting reports about the ability of other AMPK activators to
induce autophagy, e.g., glucose starvation or phenformin (<xref rid="R65" ref-type="bibr">Ramirez-Peinado et al., 2013</xref>; <xref rid="R11" ref-type="bibr">Cheong et al., 2011</xref>). These discrepancies may be caused
by differences in cell types, assay conditions, or methods to measure autophagy or
may reflect that the steps of autophagy require energy (<xref rid="R62" ref-type="bibr">Plomp et al., 1989</xref>; <xref rid="R73" ref-type="bibr">Schellens and Meijer, 1991</xref>). Phenformin, described as an inhibitor of
mitochondrial complex I (<xref rid="R56" ref-type="bibr">Owen et al., 2000</xref>),
and glucose starvation have different effects on energy metabolism by targeting
oxidative phosphorylation (OXPHOS) and glycolysis, respectively. It has been argued
that autophagy in response to glucose starvation maintains energy homeostasis by
supplying substrates for the tricarboxylic acid (TCA) cycle (<xref rid="R11" ref-type="bibr">Cheong et al., 2011</xref>), similar to reports that RAS
oncogene-driven tumors are addicted to autophagy to support metabolism and growth
(<xref rid="R22" ref-type="bibr">Guo et al., 2016</xref>; <xref rid="R93" ref-type="bibr">Yang et al., 2011</xref>). However, in cells treated with
phenformin, the role of autophagy in the switch to and support of aerobic glycolysis
is not clear. The use of phenformin is complicated by reports that it, like AICAR,
does not induce autophagy (<xref rid="R11" ref-type="bibr">Cheong et al.,
2011</xref>). Others suggest that by targeting OXPHOS, phenformin induces
selective mitophagy (<xref rid="R74" ref-type="bibr">Shackelford et al.,
2013</xref>) to maintain energy equilibrium through a mechanism that involves
phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1) and the E3
ubiquitin-protein ligase PARKIN (<xref rid="R95" ref-type="bibr">Youle and Narendra,
2011</xref>). In yeast, however, defects in mitochondrial respiration suppress
rather than induce autophagy (<xref rid="R21" ref-type="bibr">Graef and Nunnari,
2011</xref>). These inconsistencies raise questions about the level of autophagy
or mitophagy induced by phenformin or the related biguanide, metformin, a commonly
used anti-diabetic drug. Phenformin and metformin are under clinical investigation
for pathologies in which autophagy&#x02019;s role is significant, including cancer
and neurodegenerative disease (<xref rid="R42" ref-type="bibr">Lorin et al.,
2013</xref>; <xref rid="R48" ref-type="bibr">Menzies et al., 2017</xref>).
Therefore, it is critical to understand the degree to which agents that activate
AMPK affect autophagy to optimize treatments for the desired outcome.</p><p id="P10">We initially set out to compare AMPK activators with mTOR inhibitors for
their potency to induce autophagy and mitophagy. We found that phenformin and
glucose starvation had opposing effects on autophagy and mitophagy, leading to a
major shift in our understanding of how energetic stress affects autophagy.
Autophagy was suppressed by phenformin and defects in complex I but enhanced by
glucose starvation and strategies to increase mitochondrial metabolism. Furthermore,
we demonstrate that complex I activity was required for changes in phospholipid
metabolism and mitochondrial-associated membrane (MAM) formation, which were
increased by mTOR inhibition and important for autophagy. Our findings demonstrate
the importance of metabolism in the regulation of autophagy, increase our
understanding of the biological effects of clinically relevant biguanides, and
suggest strategies to activate or suppress this vital process.</p></sec><sec id="S2"><title>RESULTS</title><sec id="S3"><title>Phenformin Inhibits Autophagy</title><p id="P11">As a positive control for autophagy, we combined the allosteric and
kinase mTOR inhibitors RAD001 and BEZ235 (RB), which we had used previously in a
preclinical model of hepatocellular carcinoma (HCC) (<xref rid="R80" ref-type="bibr">Thomas et al., 2012</xref>). As an energetic stressor, we
initially chose phenformin, because it enters cells more readily than metformin
and is reported to be 10 times more potent (<xref rid="R74" ref-type="bibr">Shackelford et al., 2013</xref>). These studies were performed primarily in
HEK293 cells, which are capable of mounting a robust autophagy response to
starvation conditions or mTOR inhibitors (<xref rid="R49" ref-type="bibr">Mercer
et al., 2008</xref>, <xref rid="R50" ref-type="bibr">2009</xref>; <xref rid="R80" ref-type="bibr">Thomas et al., 2012</xref>) and are used routinely
for studies associated with mTOR and AMPK signaling (<xref rid="R3" ref-type="bibr">Auciello et al., 2014</xref>; <xref rid="R71" ref-type="bibr">Sancak et al., 2010</xref>). Consistent with our previous
work (<xref rid="R80" ref-type="bibr">Thomas et al., 2012</xref>), RB strongly
induced autophagy, as determined by the betaine homocysteine S-methyltransferase
(BHMT) autophagy cargo assay and accumulation of a glutathione S-transferase
(GST)-BHMT fragment; by increased levels of LC3-II, a marker of autophagy (<xref rid="R31" ref-type="bibr">Kabeya et al., 2000</xref>); and by decreased
levels of sequestome 1 (SQSTM1/p62), an adaptor protein that selects
ubiquitinated proteins for autophagy (<xref rid="R58" ref-type="bibr">Pankiv et
al., 2007</xref>) (<xref rid="F1" ref-type="fig">Figures 1A and 1B</xref>).
Unexpectedly, in phenformin-treated cells, BHMT fragmentation and LC3-II levels
did not increase and SQSTM1/p62 levels were stable, despite activation of AMPK
and inhibition of mTORC1 at later time points, as determined by increased
phosphorylation of acetyl-coA carboxylase (ACC) and decreased phosphorylation of
S6K1 and 4EBP1 (<xref rid="F1" ref-type="fig">Figures 1A and 1B</xref>). We
subsequently tested increasing doses of phenformin for their ability to inhibit
mTOR and induce autophagy and found that phenformin did not induce autophagy at
any dose and suppressed the amplitude of autophagy induced by RB in a
dose-dependent manner (<xref rid="F1" ref-type="fig">Figure 1C</xref>). These
results were supported by LC3-II flux analyses by western blotting (<xref rid="F1" ref-type="fig">Figures 1D and 1E</xref>) and immunofluorescence of
LC3B puncta (<xref rid="F1" ref-type="fig">Figures 1F and 1G</xref>). These
findings were not cell line or compound specific, because the biguanides
inhibited autophagy induced by mTOR inhibitors in multiple cell lines, including
liver kinase B1 (LKB1)-deficient A549 cells (<xref rid="SD1" ref-type="supplementary-material">Figures S1A&#x02013;S1C</xref>), suggesting
that AMPK activation is not required for either the induction of autophagy by RB
or its inhibition by phenformin. Expression of proteins associated with ULK1 or
class III phosphatidylinositol (PtdIns) lipid kinase, VPS34, which define
complexes that initiate autophagy were not changed by either treatment (<xref rid="SD1" ref-type="supplementary-material">Figure S1D</xref>). Finally,
rotenone and oligomycin, inhibitors of complex I and ATP synthase, respectively,
did not induce autophagy and inhibited RB-induced autophagy at two time points
(<xref rid="SD1" ref-type="supplementary-material">Figure S1E</xref>),
suggesting that respiration-competent mitochondria are essential for autophagy.
We conclude that phenformin does not induce autophagy, despite mTOR inhibition
and AMPK activation, and inhibits autophagy induced by mTOR inhibitors.</p></sec><sec id="S4"><title>Phenformin Inhibits Mitophagy</title><p id="P12">We reported that phenformin caused mitochondrial fragmentation and
dysfunction in Huh7 cells (<xref rid="R84" ref-type="bibr">Veiga et al.,
2018</xref>), conditions that are conducive for mitophagy (<xref rid="R59" ref-type="bibr">Pickles et al., 2018</xref>) and consistent with reports
that phenformin induces mitophagy (<xref rid="R18" ref-type="bibr">Egan et al.,
2011</xref>; <xref rid="R74" ref-type="bibr">Shackelford et al.,
2013</xref>). Mitochondria in phenformin-treated HEK293 cells also appeared
fragmented and shifted from dense to more buoyant fractions on a density
gradient (<xref rid="SD1" ref-type="supplementary-material">Figures S2A and
S2B</xref>). To measure mitophagy, we used the GST<sub>LSCS</sub>GFP-ActA
mitophagy assay, which detects the autolysosomal degradation of a reporter
protein embedded in the outer mitochondrial membrane (OMM) (<xref rid="R15" ref-type="bibr">Dennis and Mercer, 2009</xref>).</p><p id="P13">Mitophagy was induced in cells treated with mTOR inhibitors (RB), as
determined by increased fragmentation of GST<sub>LSCS</sub>GFP-ActA, increased
LC3-II (<xref rid="F2" ref-type="fig">Figure 2A</xref>), and a significant
reduction in mitochondrial mass (<xref rid="F2" ref-type="fig">Figure
2B</xref>). These data are consistent with our previous findings that RB induced
mitophagy in mouse liver tumors (<xref rid="R80" ref-type="bibr">Thomas et al.,
2012</xref>) and the decreased mitochondrial mass reported in cells treated
with other mTOR kinase inhibitors (<xref rid="R52" ref-type="bibr">Morita et
al., 2013</xref>). To determine whether the decreased mitochondrial mass
could be attributed to decreased mitochondrial biogenesis, we measured
expression of peroxisome proliferator-activated receptor gamma coactivator 1
alpha (PGC1&#x003b1;), nuclear-respiratory factor 1 (NRF1), and transcription
factor A, mitochondrial (TFAM), which are reported to be regulated by mTORC1
(<xref rid="R13" ref-type="bibr">Cunningham et al., 2007</xref>; <xref rid="R52" ref-type="bibr">Morita et al., 2013</xref>). However, in the
conditions used here, these transcriptional regulators were not decreased by RB
but instead were either unchanged or increased (<xref rid="SD1" ref-type="supplementary-material">Figures S2C&#x02013;S2E</xref>). Phenformin
did not induce mitophagy when used alone and inhibited RB-induced mitophagy
(<xref rid="F2" ref-type="fig">Figure 2A</xref>), similar to its inhibition
of autophagy. To confirm these data, we employed mitophagy reporter proteins
fused to Keima as described (<xref rid="R2" ref-type="bibr">An and Harper,
2018</xref>). Keima is an acid-stable fluorescent protein that emits green
or red signals at neutral or acidic pH, respectively, and has been used to
determine autophagy flux (<xref rid="R2" ref-type="bibr">An and Harper,
2018</xref>; <xref rid="R34" ref-type="bibr">Katayama et al., 2011</xref>).
In cells expressing Mito-Keima, RB induced readily identifiable discreet red
puncta suggestive of active mitophagy, whereas there was little difference in
the red signal among vehicle (V), P, or RB plus P (RBP) treatments (<xref rid="F2" ref-type="fig">Figure 2C</xref>). The mitochondrial import receptor
subunit TOMM20-Keima fusion protein on the OMM is processed by lysosomal
proteases to produce an acid-stable form of ~25 kDa. (<xref rid="R2" ref-type="bibr">An and Harper, 2018</xref>). Similar to the
GST<sub>LSCS</sub>GFP-ActA assay (<xref rid="F2" ref-type="fig">Figure
2A</xref>), the processed TOMM20-Keima fragment was increased by RB, but not
phenformin (<xref rid="SD1" ref-type="supplementary-material">Figure
S2F</xref>). In TOMM20-Keima cells that overexpressed PARKIN, Keima processing
was blunted (<xref rid="SD1" ref-type="supplementary-material">Figure
S2F</xref>), which may be because of PARKIN&#x02019;s E3 ubiquitin ligase
activity and increased proteasome degradation of OMM proteins (<xref rid="R94" ref-type="bibr">Yoshii et al., 2011</xref>). Further investigation showed
that expression of PINK1, which is stabilized on the OMM of damaged mitochondria
(<xref rid="R54" ref-type="bibr">Narendra et al., 2010</xref>), did not
change in cells treated with RB, phenformin, metformin, or rotenone, in contrast
to its robust expression in cells treated with oligomycin and antimycin A,
inhibitors of mitochondrial ATP synthase and complex III, respectively, or
carbonyl cyanide 3-chlorophenyl hydrazone (CCCP), a mitochondrial uncoupler
(<xref rid="SD1" ref-type="supplementary-material">Figure S2G</xref>). The
increased mitophagy observed with RB correlated with decreased levels of TOM20
on the OMM (<xref rid="SD1" ref-type="supplementary-material">Figure
S2G</xref>), but not with cytochrome c oxidase assembly protein COX II on the
inner mitochondrial membrane (IMM) (<xref rid="F2" ref-type="fig">Figure
2A</xref>). Furthermore, mitochondrial complex I activity was increased in
mitochondria from RB-treated cells but was not significantly changed by
phenformin (<xref rid="F2" ref-type="fig">Figure 2D</xref>). The assay employed
for these measurements does not depend on ubiquinone, so complex I inhibitors
that interfere with the ubiquinone binding site, such as rotenone (<xref rid="R57" ref-type="bibr">Palmer et al., 1968</xref>), do not inhibit
activity. Phenformin may work through a similar mechanism. We conclude that
RB-induced mitophagy is distinct from a PINK1/PARKIN mechanism of mitophagy and
is a type of mitochondrial remodeling that preserves complex I activity. We
found no evidence of mitophagy in phenformin-treated cells, which may be partly
because of the lack of PINK1 stabilization. Despite this, phenformin inhibited
mitophagy induced by RB, suggesting that a common mechanism underlies
phenformin&#x02019;s inhibition of both autophagy and mitophagy.</p></sec><sec id="S5"><title>Phenformin&#x02019;s Inhibition of Autophagy Is Not Explained by Lysosome
Defects</title><p id="P14">The inhibition of autophagy by phenformin could be attributed to several
mechanisms, including inhibition of mitochondrial complex I, mitochondrial
glycerophosphate dehydrogenase, one-carbon metabolism, or the lysosome (<xref rid="R12" ref-type="bibr">Corominas-Faja et al., 2012</xref>; <xref rid="R41" ref-type="bibr">Lockwood, 2010</xref>; <xref rid="R43" ref-type="bibr">Madiraju et al., 2014</xref>; <xref rid="R56" ref-type="bibr">Owen et al., 2000</xref>). The latter was of particular
interest, because lysosome dysfunction inhibits both mTORC1 and autophagy (<xref rid="R1" ref-type="bibr">Amaravadi et al., 2011</xref>; <xref rid="R98" ref-type="bibr">Zoncu et al., 2011</xref>) and metformin and phenformin
inhibit mTORC1 through a Rag-guanosine triphosphatase (GTPase)-dependent
mechanism at the lysosome (<xref rid="R33" ref-type="bibr">Kalender et al.,
2010</xref>). We reasoned that if phenformin inhibited mTORC1 by inhibiting
lysosomal function, then mTORC1 would be insensitive to amino acid starvation if
it was tethered to the lysosome, as shown in cells expressing FLAG-RAPTOR-RHEB15
(<xref rid="R71" ref-type="bibr">Sancak et al., 2010</xref>). In control
cells that expressed FLAG-RAPTOR, chloroquine (CQ), a lysosome inhibitor, and
phenformin both inhibited mTORC1 activity in response to amino acid stimulation
(<xref rid="SD1" ref-type="supplementary-material">Figure S3A</xref>).
However, in cells that express FLAG-RAPTOR-RHEB15, mTORC1 activity was protected
from amino acid starvation in CQ-treated cells, as expected, but only partially
protected by phenformin. Furthermore, phenformin inhibited mTORC1 in amino
acid-starved FLAG-RAPTOR-RHEB15 cells that were co-treated with CQ, suggesting
that a significant part of phenformin&#x02019;s action is independent of the
lysosome (<xref rid="SD1" ref-type="supplementary-material">Figure S3A</xref>).
In support of this conclusion, LC3-II or LC3B puncta did not accumulate in
phenformin-treated cells (<xref rid="F1" ref-type="fig">Figures 1A and
1D&#x02013;1F</xref>) and lysosomal pH was unchanged by phenformin (<xref rid="SD1" ref-type="supplementary-material">Figure S3B</xref>).</p></sec><sec id="S6"><title>Defects in Mitochondrial Complex I Suppress Autophagy</title><p id="P15">To determine whether phenformin&#x02019;s inhibition of autophagy was
related to complex I inhibition, we measured autophagy in cells with genetic
deletion of complex I accessory subunits whose importance in complex I assembly
and activity was described by <xref rid="R77" ref-type="bibr">Stroud et al.,
(2016)</xref>. We chose four knockout (KO) cell lines for these experiments:
<italic>NDUFS6</italic><sup>KO</sup> and
<italic>NDUFS4</italic><sup>KO</sup> lines, which are viable in galactose
media and relatively competent in complex I assembly, and
<italic>NDUFA1</italic><sup>KO</sup> and
<italic>NDUFA1</italic>0<sup>KO</sup> lines, which are not viable in
galactose media and have severe defects in complex I assembly (<xref rid="R77" ref-type="bibr">Stroud et al., 2016</xref>). Basal mTORC1 activity appeared
to be decreased in the KO cells, whereas AMPK activity was increased only in the
cells with the more severe defect. In <italic>NDUFS6</italic><sup>KO</sup> and
<italic>NDUFS4</italic><sup>KO</sup> cells, RB-induced autophagy was nearly
as robust as autophagy in RB-treated control cells and was inhibited by
phenformin to a similar degree (Figures <xref rid="F3" ref-type="fig">3A</xref>
and <xref rid="SD1" ref-type="supplementary-material">S3C</xref>). In contrast,
the amplitude of RB-induced autophagy was reduced in
<italic>NDUFA1</italic>0<sup>KO</sup> and
<italic>NDUFA1</italic><sup>KO</sup> cells and was not further decreased by
the addition of phenformin (Figures <xref rid="F3" ref-type="fig">3A</xref> and
<xref rid="SD1" ref-type="supplementary-material">S3C</xref>), suggesting
that phenformin&#x02019;s inhibition of autophagy is primarily mediated by
inhibition of complex I. BHMT fragmentation in vehicle-treated NDUF KO cells was
less than in control cells (Figures <xref rid="F3" ref-type="fig">3A</xref> and
<xref rid="SD1" ref-type="supplementary-material">S3C</xref>), suggesting
that basal autophagy is suppressed by chronic defects in complex I.</p><p id="P16">Inhibition of complex I is reported to increase NADH and NADH/NAD+
ratios (<xref rid="R5" ref-type="bibr">Birsoy et al., 2015</xref>; <xref rid="R78" ref-type="bibr">Sullivan et al., 2015</xref>), and levels and
metabolism of NAD+, the oxidized member of this redox pair, have been linked to
the regulation of autophagy (reviewed in <xref rid="R29" ref-type="bibr">Jang et
al., 2012</xref>). Therefore, we asked whether phenformin&#x02019;s
inhibition of autophagy could be explained by changes in NADH/NAD+ ratios. We
first determined that phenformin treatment increased the NADH/NAD+ ratio in
HEK293 cells, which was largely reversed by the addition of mTOR inhibitors
(<xref rid="SD1" ref-type="supplementary-material">Figure S3D</xref>).
Although supplementation with nicotinamide (NM) to increase NAD+ biosynthesis
decreased NADH/NAD+ ratios (<xref rid="SD1" ref-type="supplementary-material">Figure S3D</xref>), NM did not induce autophagy when used alone; it
decreased RB-induced autophagy and did not rescue phenformin&#x02019;s inhibition
of RB autophagy (Figures <xref rid="F3" ref-type="fig">3B</xref> and <xref rid="SD1" ref-type="supplementary-material">S3E</xref>). The lack of
correlation between NADH/NAD+ ratios and autophagy suggests that increased NADH
does not explain the autophagy defect associated with phenformin.</p><p id="P17">Finally, as with autophagy, RB-induced mitophagy was impaired in
<italic>NDUFA1</italic><sup>KO</sup> cells compared to control cells (<xref rid="F3" ref-type="fig">Figure 3C</xref>), without further inhibition by
phenformin. Although CCCP did not induce measurable mitophagy in either cell
line (<xref rid="F3" ref-type="fig">Figure 3C</xref>), we could occasionally
detect modest mitophagy in CCCP-treated HEK293 cells, but only at shorter time
points (<xref rid="SD1" ref-type="supplementary-material">Figure S3F</xref>).
PINK1 expression, although less robust in HEK293T cells compared to HEK293
cells, was not increased in vehicle-treated <italic>NDUFA1</italic><sup>KO</sup>
cells (<xref rid="F3" ref-type="fig">Figure 3C</xref>), suggesting that complex
I defects do not activate PINK1-mediated mitophagy. Phenformin and CCCP both
induced cleavage of the IMM GTPase optic atrophy 1 (OPA1), an energetic stress
response that inhibits membrane fusion activity (<xref rid="R81" ref-type="bibr">Toyama et al., 2016</xref>), consistent with mitochondrial fragmentation
(<xref rid="SD1" ref-type="supplementary-material">Figures S2A and
S2B</xref>) (<xref rid="R84" ref-type="bibr">Veiga et al., 2018</xref>) and
supporting the efficacy of phenformin in these cells. Altogether, these data
show that defects in complex I and mitochondrial respiration suppress autophagy
in higher eukaryotes, similar to what has been reported in yeast (<xref rid="R21" ref-type="bibr">Graef and Nunnari, 2011</xref>).</p></sec><sec id="S7"><title>Phenformin and Glucose Starvation Increase AMP/ATP Energy Ratios and Cause
Compensatory Metabolic Switching</title><p id="P18">The suppression of autophagy and mitophagy by phenformin led us to
question whether there was sufficient energy in phenformin-treated cells to
support autophagy. Although it is widely accepted that autophagy responds to
energetic stress to increase survival (<xref rid="R45" ref-type="bibr">Meijer
and Codogno, 2011</xref>), autophagy consumes ATP (<xref rid="R62" ref-type="bibr">Plomp et al., 1989</xref>), which suggests that cells must
maintain an energetic threshold to support autophagy. Adding adenosine to DMEM,
which has been reported to increase ATP when used at millimolar concentrations
(<xref rid="R38" ref-type="bibr">Li et al., 2013</xref>), significantly
increased ATP levels in HEK293 cells (<xref rid="SD1" ref-type="supplementary-material">Figure S4A</xref>), decreased
phosphorylation of ACC, and enhanced autophagy in response to mTOR inhibitors
(<xref rid="F4" ref-type="fig">Figure 4A</xref>) supporting the importance
of ATP in fueling autophagy. To determine the energetic status of cells in
conditions that induced or inhibited autophagy, we measured AMP/ATP energy
ratios at 1, 6, and 24 hr in cells treated with RB and/or phenformin. For
comparison, we included glucose-starved cells as an alternative means to induce
energy stress. In RB-treated cells, the slight increase in the AMP/ATP ratio at
1 hr adjusted to control levels over time (<xref rid="F4" ref-type="fig">Figure
4B</xref>). In contrast, AMP/ATP ratios in cells treated with phenformin or
starved of glucose for 1 hr increased more than 25-fold (<xref rid="F4" ref-type="fig">Figure 4B</xref>) with partial recovery over time, as cells
presumably adjusted to the energetic stress by switching from OXPHOS to
glycolysis, or vice versa. In support of such a switch, phenformin significantly
increased lactate at 2 time points in both cells and media, decreased glucose
levels, and depleted glycogen stores (<xref rid="SD1" ref-type="supplementary-material">Figures S4B&#x02013;S4F</xref>), consistent
with glucose consumption and a shift toward aerobic glycolysis. In contrast,
lactate levels in glucose-starved cells were significantly decreased (<xref rid="SD1" ref-type="supplementary-material">Figure S4C</xref>), and the
metabolites 3-hydroxyisobutyrate, 2-oxoisocaproate, and 3-methyl-2-oxovalerate
were increased in cells and/or media (<xref rid="SD1" ref-type="supplementary-material">Figures S4G and S4H</xref>), consistent
with the catabolism of branched chain amino acids BCAA to fuel the TCA cycle
(<xref rid="R96" ref-type="bibr">Zhang et al., 2017</xref>). The metabolic
changes in RB-treated cells more closely resembled glucose starvation than
phenformin treatment (<xref rid="SD1" ref-type="supplementary-material">Figures
S4B&#x02013;S4E, S4G, and S4H</xref>). In phenformin-treated cells, the
nearly complete recovery of AMP/ATP ratios at 6 hr was not lasting but instead
increased again at 24 hr (<xref rid="F4" ref-type="fig">Figure 4B</xref>), a
rise that paralleled increasing phosphorylation of ACC (Figures <xref rid="F1" ref-type="fig">1A</xref> and<xref rid="F4" ref-type="fig">4E</xref>).</p></sec><sec id="S8"><title>Phenformin Suppresses the Initiation, Amplitude, and Duration of
Autophagy</title><p id="P19">We predicted that if phenformin&#x02019;s inhibition of RB-induced
autophagy was due to energy depletion, it was likely to occur at early time
points when energy ratios were most severely affected. The WD-40 repeat domain
phosphoinositide-interacting protein 2 (WIPI2) is a mammalian Atg18 ortholog
that is recruited to early autophagosome structures, where it binds PtdIns3P, a
product of VPS34/ATG14/BECLIN1 complex activity, and supports LC3 lipidation
(<xref rid="R63" ref-type="bibr">Polson et al., 2010</xref>). We observed a
decrease in WIPI2 puncta and the rate of LC3-II accumulation in RBP-treated
cells, compared to RB treatment (Figures <xref rid="F4" ref-type="fig">4C</xref>, <xref rid="F4" ref-type="fig">4D</xref>, and <xref rid="SD1" ref-type="supplementary-material">S4H&#x02013;S4K</xref>), suggesting that
phenformin decreased early autophagosome formation. Despite this, there was
little difference in the GST-BHMT fragment between cells treated with RB or RBP
at 2 hr (Figures <xref rid="F4" ref-type="fig">4E</xref> and<xref rid="F4" ref-type="fig">4F</xref>) or in SQSTM1/p62 levels (<xref rid="F1" ref-type="fig">Figure 1D</xref>), suggesting that the decreased rate of
autophagosome formation had little effect on the initial sequestration,
delivery, or degradation of autophagy cargo. At subsequent time points, however,
the amplitude of autophagy in RBP cells fell below that of RB-treated cells.
Furthermore, in contrast to the stability of the GST-BHMT fragment in RB-treated
cells (<xref rid="F1" ref-type="fig">1A</xref> and<xref rid="F4" ref-type="fig">4E</xref>), the reporter fragment in RBP-treated cells declined after 8 hr
(<xref rid="F4" ref-type="fig">Figures 4E and 4F</xref>). The fragment decay
is consistent with attenuated autophagy and decreased cargo delivery; we could
induce a similar decrease in BHMT fragment levels by treating cells 5 hr after
the onset of autophagy with agents that disrupt vesicle trafficking or
autophagosome and lysosome fusion (<xref rid="SD1" ref-type="supplementary-material">Figures S4M and S4N</xref>). We conclude
that (1) although ATP clearly supports autophagy, severe defects in energetic
ratios do not prevent the initial sequestration of autophagic cargo induced by
mTOR inhibitors, and (2) phenformin suppresses autophagy progression through a
defect in autophagosome biogenesis.</p></sec><sec id="S9"><title>Prolonged Glucose Starvation Increases Autophagy and Mitophagy</title><p id="P20">Although the effects of glucose starvation and phenformin on AMP/ATP
ratios were similar, their effects on autophagy were different. In
glucose-starved cells, GST-BHMT fragmentation and LC3-II levels, although
initially unchanged, were increased at 24 hr (<xref rid="F5" ref-type="fig">Figure 5A</xref>), consistent with reports that glucose starvation induces
autophagy (<xref rid="R11" ref-type="bibr">Cheong et al., 2011</xref>; <xref rid="R36" ref-type="bibr">Kim et al., 2011</xref>). However, there was
little correlation between the kinetics of AMPK activation, which occurred
early, and the late induction of autophagy. In RB-treated cells, autophagy in
glucose-depleted medium at early time points was comparable to autophagy in
high-glucose DMEM but exceeded that of RB in high glucose at 24 hr and was
stable up to 36 hr (Figures <xref rid="F5" ref-type="fig">5A</xref>, <xref rid="F5" ref-type="fig">5B</xref>, and <xref rid="SD1" ref-type="supplementary-material">S5A</xref>). Consistent with these
findings, replacing glucose with either galactose, which provides no net ATP
from aerobic glycolysis (<xref rid="R44" ref-type="bibr">Marroquin et al.,
2007</xref>), or trehalose, a non-fermentable sugar that inhibits glucose
transport (<xref rid="R14" ref-type="bibr">DeBosch et al., 2016</xref>), also
increased autophagy and enhanced RB-induced autophagy (<xref rid="F5" ref-type="fig">Figure 5C</xref>). It is likely that glucose-starved cells
use TCA substrates like glutamine to support OXPHOS and survival (<xref rid="R91" ref-type="bibr">Wise and Thompson, 2010</xref>). Consistent with
the importance of mitochondrial function for autophagy, supplementation of
glucose-replete DMEM with the anapleurotic amino acids glutamine or aspartate
increased the amplitude of RB-induced autophagy, although neither amino acid
rescued the autophagy defect in cells treated with RBP (<xref rid="SD1" ref-type="supplementary-material">Figures S5B and S5C</xref>), consistent
with a phenformin defect in complex I and OXPHOS. Finally, mitophagy in response
to glucose starvation or galactose treatment was nearly as robust as mitophagy
in RB-treated cells (<xref rid="F5" ref-type="fig">Figure 5D</xref>) but was not
observed in cells starved of essential amino acids (<xref rid="SD1" ref-type="supplementary-material">Figure S5D</xref>). We conclude that
metabolic conditions that favor mitochondrial function and respiration also
increase the amplitude of autophagy and mitophagy, independent of unfavorable
AMP/ATP energy ratios.</p></sec><sec id="S10"><title>Phospholipid Remodeling in Autophagy</title><p id="P21">The lack of correlation between energetic ratios and autophagy led us to
consider phenformin&#x02019;s effects on phosphatidylethanolamine (PE)
biosynthesis. Levels of lipidated LC3-II were often decreased in cells treated
for 24 hr with phenformin (Figures <xref rid="F4" ref-type="fig">4E, 4G</xref>,
<xref rid="F5" ref-type="fig">5D</xref>, and <xref rid="SD1" ref-type="supplementary-material">S5D</xref>), suggesting that phenformin
may limit either the synthesis or the availability of PE, a phospholipid that is
covalently attached to membrane-bound LC3 (<xref rid="R32" ref-type="bibr">Kabeya et al., 2004</xref>) and required for autophagy (<xref rid="R66" ref-type="bibr">Rockenfeller et al., 2015</xref>). Using targeted
lipidomics, we found that phenformin alone had little effect on phospholipids,
whereas RB significantly increased select species of PE and phosphatidylserine
(PS) (Figures <xref rid="F6" ref-type="fig">6A</xref>, <xref rid="SD1" ref-type="supplementary-material">S6A, and S6B</xref>). PE (18:0/18:1)
levels did not increase in cells treated with RBP, consistent with
phenformin&#x02019;s inhibition of RB-induced autophagy. In mammalian cells,
distinct pools of PE are synthesized on either mitochondria or endoplasmic
reticulum (ER) membranes (<xref rid="R83" ref-type="bibr">Vance and Tasseva,
2013</xref>), and the mitochondrial phosphatidylethanolamine (mtPE) pool is
reported to support autophagosome formation in starved cells (<xref rid="R24" ref-type="bibr">Hailey et al., 2010</xref>). To determine the importance of
mtPE for RB autophagy, we measured autophagy in cells with 2 small interfering
RNAs (siRNAs) targeting PISD, an IMM enzyme that converts PS to mtPE. Cells with
silencing phosphatidylserine decarboxylase (siPISD) were visibly stressed, with
cleaved poly(ADP-ribose) polymerase 1 (PARP), indicative of early apoptosis, in
siPISD-6 cells with the more severe knockdown (Figures <xref rid="F6" ref-type="fig">6B</xref> and <xref rid="SD1" ref-type="supplementary-material">S6C</xref>). These data are consistent
with reports that loss of PISD causes defects in mitochondrial morphology and
function, disrupts electron transport chain (ETC) complex formation, and is
embryonic lethal in mice (reviewed in <xref rid="R83" ref-type="bibr">Vance and
Tasseva, 2013</xref>). Basal autophagy was increased only in siPISD-6 cells,
suggesting that the more severe PISD depletion induced a type of autophagy
associated with apoptosis, a phenomenon also observed with the chemotherapy drug
doxorubicin (<xref rid="SD1" ref-type="supplementary-material">Figure
S6D</xref>). Despite this, the magnitude of RB-induced autophagy was decreased
by knockdown of siPISD when compared to nonsilencing siRNA (siNS) control cells,
and was further reduced by the addition of phenformin (<xref rid="F6" ref-type="fig">Figure 6B</xref>). The latter suggests that complex I
assembly was not fully compromised by partial PISD knockdown. To inhibit PISD
more acutely, we used the PISD inhibitor hydroxylamine (<xref rid="R75" ref-type="bibr">Shiao et al., 1995</xref>; <xref rid="R86" ref-type="bibr">Voelker, 1993</xref>), which inhibited RB-induced autophagy without signs
of apoptosis when used at 0.1 or 1 mM doses (<xref rid="SD1" ref-type="supplementary-material">Figure S6D</xref>). Others have shown that
PISD activity is increased by exogenous serine (<xref rid="R75" ref-type="bibr">Shiao et al., 1995</xref>; <xref rid="R86" ref-type="bibr">Voelker,
1993</xref>), a non-essential amino acid that supports PS, sphingosine, and
purine biosynthesis (<xref rid="R40" ref-type="bibr">Locasale, 2013</xref>).
Adding serine to DMEM increased the amplitude of RB autophagy, which was
reversed by the PISD inhibitor hydroxylamine (<xref rid="F6" ref-type="fig">Figure 6C</xref>), supporting the importance of PISD activity and mtPE for
autophagy. The addition of ethanolamine (ETN) to medium to favor ER biosynthesis
of PE through the Kennedy pathway (<xref rid="R9" ref-type="bibr">Calzada et
al., 2016</xref>) or mixed phospholipid liposomes also increased the
amplitude of RB autophagy, although neither rescued the autophagy defect
associated with phenformin (Figures <xref rid="F6" ref-type="fig">6D</xref> and
<xref rid="SD1" ref-type="supplementary-material">S6F</xref>). We conclude
that mTOR inhibitors enhance both phospholipid remodeling and autophagy that
depends on PISD activity and mtPE, as well as that phenformin blocks the
biosynthesis of mtPE.</p></sec><sec id="S11"><title>Phenformin Blocks MAMs that Support Autophagy</title><p id="P22">We reasoned that phenformin might affect mtPE biosynthesis under
autophagy-inducing conditions by limiting the availability of PS, the substrate
for PISD (<xref rid="R16" ref-type="bibr">Di Bartolomeo et al., 2017</xref>). PS
translocates from the ER to mitochondria at MAMs, which are regions of proximity
between the ER and the mitochondria that support mitochondrial function (<xref rid="R53" ref-type="bibr">Naon and Scorrano, 2014</xref>) and autophagy, the
latter through recruitment of ATG14 and VPS34 (<xref rid="R25" ref-type="bibr">Hamasaki et al., 2013</xref>). To determine the effect of our treatments on
MAM formation, we used a proximity ligation assay with antibodies to inositol
trisphosphate receptor (IP3R) and voltage-dependent anion channel (VDAC) on the
ER and the OMM, respectively. We found that RB significantly increased the
number of MAM contact sites compared to vehicle control (<xref rid="F7" ref-type="fig">Figures 7A and 7B</xref>), consistent with the increase of
WIPI2 puncta (<xref rid="F4" ref-type="fig">Figures 4C and 4D</xref>), and
autophagosome formation at MAMs (<xref rid="R25" ref-type="bibr">Hamasaki et
al., 2013</xref>). Phenformin alone had little effect on MAM formation, but
when combined with RB, it reduced the number of MAM contact sites compared to RB
alone (<xref rid="F7" ref-type="fig">Figures 7A and 7B</xref>). Moreover, MAMs
did not increase in <italic>NDUFA1</italic><sup>KO</sup> cells treated with RB
(<xref rid="F7" ref-type="fig">Figures 7A and 7B</xref>), supporting the
importance of complex I activity for autophagy. Finally, prolonged glucose
starvation, which induced both a metabolic shift toward OXPHOS and autophagy
(Figures <xref rid="F5" ref-type="fig">5</xref>, <xref rid="SD1" ref-type="supplementary-material">S5, and S4</xref>), increased MAM
formation to levels equivalent to RB treatment (<xref rid="SD1" ref-type="supplementary-material">Figure S7</xref>), consistent with reports
that MAM formation is sensitive to glucose availability (<xref rid="R79" ref-type="bibr">Theurey et al., 2016</xref>). Altogether, these data support
a model in which complex I activity is required to facilitate the transport of
PS from the ER to mitochondria at MAMs, supplying PS substrate for the
biosynthesis of mtPE and supporting both respiratory function and autophagy
(<xref rid="F7" ref-type="fig">Figure 7C</xref>).</p></sec></sec><sec id="S12"><title>DISCUSSION</title><sec id="S13"><title>Mitochondrial Metabolism Supports Autophagy</title><p id="P23">Understanding the relationship between autophagy and metabolism has
previously focused on how autophagy fuels metabolism, supporting cell survival
(<xref rid="R37" ref-type="bibr">Kimmelman and White, 2017</xref>). Our data
demonstrate that a reciprocal relationship is also true, with metabolism
regulating the amplitude of the autophagy response. We showed that a metabolic
shift toward aerobic glycolysis decreased autophagy, whereas a shift toward
OXPHOS increased the amplitude of autophagy, most strikingly in response to mTOR
inhibitors. In the setting of cancer, the high metabolic demand of tumor cells,
particularly those with activated RAS signaling, often depends on autophagy
(<xref rid="R37" ref-type="bibr">Kimmelman and White, 2017</xref>), leading
to clinical trials using lysosomal inhibitors to target autophagy directly and
metabolism indirectly. Our data suggest that targeting mitochondrial OXPHOS for
cancer therapy (<xref rid="R88" ref-type="bibr">Weinberg and Chandel,
2015</xref>) will inhibit both mitochondrial metabolism and autophagy.</p><p id="P24">Clinically, there is considerable interest in using metformin and
phenformin for cancer treatment (<xref rid="R88" ref-type="bibr">Weinberg and
Chandel, 2015</xref>), with nearly 100 actively recruiting clinical trials
(<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/">https://clinicaltrials.gov/</ext-link>). Our data show
that biguanides inhibit mTORC1 without the complication of activating autophagy
and cause a metabolic shift toward glycolysis. We reported that the sequential
use of phenformin and RB significantly prolonged survival in a mouse model of
HCC, suggesting that phenformin metabolically sensitized HCC tumors to mTOR
inhibitors (<xref rid="R84" ref-type="bibr">Veiga et al., 2018</xref>). It
remains to be determined whether phenformin pretreatment blocked RB-induced
autophagy <italic>in vivo</italic>, contributing to the efficacy of the
combination. For tumors that are addicted to autophagy, the potential use of
biguanides as autophagy inhibitors provides an alternative to CQ or
hydroxychloroquine, without the disadvantages associated with profound lysosomal
inhibition.</p></sec><sec id="S14"><title>Complex I Defects Suppress Autophagy</title><p id="P25">We found lower basal autophagy in NDUF KO cells and an inverse
correlation between the severity of the complex I defect and the amplitude of
RB-induced autophagy. Mutations in each of the complex I assembly subunits used
here have been implicated in Leigh syndrome, a pediatric mitochondrial disease
marked by progressive neurodegeneration and early death (<xref rid="R67" ref-type="bibr">Rodenburg, 2016</xref>). Suppression of basal autophagy in
mice with neuronal deletion of ATG5 was a contributing factor to their
neurodegeneration (<xref rid="R26" ref-type="bibr">Hara et al., 2006</xref>),
suggesting that defects in autophagy may contribute to the pathology of Leigh
syndrome and other mitochondrial diseases. Rapamycin has been shown to slow
disease progression in an
<italic>NDUFS4</italic><sup><italic>&#x02212;</italic>/&#x02212;</sup>mouse
model of Leigh syndrome (<xref rid="R30" ref-type="bibr">Johnson et al.,
2013</xref>) and in induced pluripotent stem cells (iPSCs) derived from a
Leigh syndrome patient (<xref rid="R97" ref-type="bibr">Zheng et al.,
2016</xref>). In the NDUF KO cells used here, RB treatment induced varying
degrees of autophagy above basal levels, albeit lower than that of wild-type
(WT) cells. It will be important to determine whether more potent mTOR kinase
inhibitors will provide an improved benefit in models of mitochondrial disease
and whether autophagy and mitophagy are contributing factors.</p></sec><sec id="S15"><title>AMP/ATP Energy Ratios, AMPK, and Autophagy</title><p id="P26">These data redefine how energetic stress affects autophagy, a dynamic
program that requires energy for its execution (<xref rid="R45" ref-type="bibr">Meijer and Codogno, 2011</xref>; <xref rid="R62" ref-type="bibr">Plomp et
al., 1989</xref>). A paradox of these studies is that RB-induced autophagy
was amplified by both energy excess (adenosine) and energy deprivation (glucose
starvation). Strategies to decrease ATP and activate AMPK did not acutely
activate autophagy, although autophagy was measurably increased by prolonged
glucose starvation. These data are consistent with those of <xref rid="R11" ref-type="bibr">Cheong et al. (2011)</xref>, who argued that autophagy in
response to glucose starvation is not due to bioenergetics failure but is
instead caused by the accumulation of ammonia, an explanation that is consistent
with much of our data. However, the finding that autophagy was increased when
galactose was used as a carbon source argues for another mechanism, because
galactose metabolism consumes ammonia but does not increase it (<xref rid="R68" ref-type="bibr">Roser et al., 2009</xref>). One explanation to resolve the
energy and autophagy paradox is that cells that switch to, or enhance,
mitochondrial OXPHOS increase ATP in a temporal and spatial manner at MAMs,
where the ATPdependent processes of PS transport and autophagosome formation are
active (<xref rid="R25" ref-type="bibr">Hamasaki et al., 2013</xref>; <xref rid="R75" ref-type="bibr">Shiao et al., 1995</xref>). This idea is supported
by the presence of the ATP transporter VDAC at MAMs (<xref rid="R53" ref-type="bibr">Naon and Scorrano, 2014</xref>).</p><p id="P27">There was little correlation between acute AMPK activation and the late
onset of autophagy in glucose-starved cells. Our data suggest that in cells with
intact complex I function, mTOR inhibition is dominant in the acute activation
of autophagy, whereas AMPK supports a second wave in a biphasic autophagy
mechanism. The delayed effect could be explained by transcriptional changes
(<xref rid="R61" ref-type="bibr">Pietrocola et al., 2013</xref>; <xref rid="R76" ref-type="bibr">Shin et al., 2016</xref>) or through the effects
of increased &#x003b2;-oxidation, as suggested (<xref rid="R8" ref-type="bibr">Buzzai et al., 2005</xref>; <xref rid="R11" ref-type="bibr">Cheong et al.,
2011</xref>). However, these effects do not explain the relevance of
AMPK&#x02019;s acute phosphorylation of ULK1 that has been linked to autophagy
(<xref rid="R18" ref-type="bibr">Egan et al., 2011</xref>; <xref rid="R36" ref-type="bibr">Kim et al., 2011</xref>). We propose that because ULK1 and
ULK2 are dispensable for glucose starvation autophagy (<xref rid="R11" ref-type="bibr">Cheong et al., 2011</xref>), AMPK phosphorylation of ULK1/2
may be linked to either selective autophagy and/or metabolism. Consistent with
this idea, Snf1 and Atg1, the yeast orthologs of AMPK and ULK1, control
glycogen-specific autophagy (<xref rid="R87" ref-type="bibr">Wang et al.,
2001</xref>), and the ULKs regulate glucose metabolic flux in starved cells
independent of autophagy (<xref rid="R39" ref-type="bibr">Li et al.,
2016</xref>). Additional studies are needed to more fully delineate the AMPK-ULK
axis in glucose metabolism.</p></sec><sec id="S16"><title>mTOR Inhibitors Increase Mitophagy</title><p id="P28">mTOR inhibitors and glucose starvation induced measurable and sustained
mitophagy while preserving complex I activity, consistent with a report that
mitophagy is induced by conditions that favor mitochondrial OXPHOS to optimize
mitochondrial efficiency (<xref rid="R47" ref-type="bibr">Melser et al.,
2013</xref>). In contrast, phenformin did not induce mitophagy, and the
response to CCCP was nearly undetectable. Furthermore, mitophagy following
prolonged CCCP treatment was lower than in vehicle-treated cells and comparable
to levels found in <italic>NDUFA1</italic> KO cells, consistent with the idea
that mitochondrial function and mitophagy are mutually dependent. RB-induced
mitophagy was independent of PINK1, which cooperates with PARKIN to remove
damaged mitochondria. Mutations in PINK1 and PARKIN are associated with
Parkinson&#x02019;s disease (PD), implicating defective mitophagy in disease
pathogenesis (<xref rid="R60" ref-type="bibr">Pickrell and Youle, 2015</xref>).
Our data suggest that the potent mitophagy induced by mTOR inhibitors could
serve as a mitochondrial quality mechanism independent of PINK1/ PARKIN
mitophagy for PD patients. Consistent with this idea, rapamycins have shown
promise in models of PD and other neurodegenerative diseases (<xref rid="R6" ref-type="bibr">Bov&#x000e9; et al., 2011</xref>). More potent mTOR kinase
inhibitors may provide additional benefit for PD treatment, and their efficacy
might be improved by metabolic strategies to amplify autophagy. Of these,
trehalose and ETN have shown promise as agents to protect against aggregates
associated with neurodegenerative disease or promote longevity (<xref rid="R66" ref-type="bibr">Rockenfeller et al., 2015</xref>; <xref rid="R72" ref-type="bibr">Sarkar et al., 2007</xref>). We hypothesize that complete
inhibition of mTORC1 triggers selective mitophagy, just as it selectively
regulates energetically costly biosynthetic pathways through post-translational
modifications. This is consistent with the idea that mTORC1 coordinates both
mitochondrial mass and protein synthesis to balance energetic output with demand
(<xref rid="R52" ref-type="bibr">Morita et al., 2013</xref>).</p></sec><sec id="S17"><title>MAMs and mtPE Play a Significant Role in Autophagy</title><p id="P29">PE is a positive regulator of autophagy (<xref rid="R66" ref-type="bibr">Rockenfeller et al., 2015</xref>); however, autophagy competes with other
PE-consuming processes for the available phospholipid pool (<xref rid="R90" ref-type="bibr">Wilson-Zbinden et al., 2015</xref>), suggesting that PE is
limiting for autophagy. mTOR inhibitors increased the abundance of select
phospholipids, in correlation with increased autophagy. The increase in C18:0
and C18:1 phospholipid acyl chains are consistent with those identified in
PE-lipidated Atg8 (<xref rid="R27" ref-type="bibr">Ichimura et al.,
2000</xref>). We conclude, based on several pieces of evidence, that mtPE is the
relevant species for autophagy. First, RB autophagy was suppressed by inhibiting
PISD and increased with exogenous serine, which is purported to increase PISD
activity (<xref rid="R75" ref-type="bibr">Shiao et al., 1995</xref>; <xref rid="R86" ref-type="bibr">Voelker, 1993</xref>). Serine and hydroxylamine
may have other effects that are relevant for autophagy apart from PISD activity,
requiring future work to validate their specific effects on mtPE biosynthesis in
this context. Second, data showing that phenformin blocked the ability of ETN
and phospholiposomes to increase RB-induced autophagy, and the RB-associated
increase in MAMs, supports the importance of PS transport and substrate
availability for PISD activity. This is related to PS transport being regulated
by mitochondria respiration in yeast and mammalian cells (<xref rid="R51" ref-type="bibr">Miyata et al., 2016</xref>; <xref rid="R75" ref-type="bibr">Shiao et al., 1995</xref>). We propose that the increased autophagy
observed with adenosine, glutamine, and aspartate is partly due to increased
respiration, phospholipid transport, and mtPE biosynthesis. The possibility that
PISD supports autophagy simply by promoting ETC activity cannot be ruled out.
However, the increase in PE and autophagy, but not ATP, in cells treated with
mTOR inhibitors, and the initiation of autophagy in energetically stressed
cells, favors the importance of PISD-derived mtPE for autophagy. Future studies
are needed to determine the physiological relevance of strategies that combine
mTOR inhibition with manipulation of mtPE biosynthesis in pathologies in which
autophagy is relevant. We are drawn to several hypotheses regarding how
phenformin inhibits mtPE biosynthesis, each of which requires further
investigation. First, mitochondrial fragmentation and the imbalance of fission
to fusion may not be conducive to inter-organelle contact. The converse is true,
because positive signals for autophagy, e.g., starvation or mTOR inhibitors,
promote fusion, OXPHOS (<xref rid="R20" ref-type="bibr">Gomes et al.,
2011</xref>; <xref rid="R84" ref-type="bibr">Veiga et al., 2018</xref>), and
MAMs (data in this paper; <xref rid="R7" ref-type="bibr">Bravo-Sagua et al.,
2016</xref>; <xref rid="R79" ref-type="bibr">Theurey et al., 2016</xref>).
Second, decreased respiration may change the expression of proteins required for
PS transport, as shown in yeast (<xref rid="R51" ref-type="bibr">Miyata et al.,
2016</xref>), or decrease the local availability of ATP for PS transport and
MAM formation. Finally, we cannot rule out that post-translation modifications
control MAM formation in a more acute manner. Altogether, these data demonstrate
the dynamic and metabolic regulation of autophagy, highlighting the importance
of mitochondrial complex I and respiration for a robust autophagy response.</p></sec></sec><sec id="S18"><title>STAR&#x02729;METHODS</title><p id="P30">Detailed methods are provided in the online version of this paper and
include the following:</p><list list-type="bullet" id="L1"><list-item><p id="P31">KEY RESOURCES TABLE</p></list-item><list-item><p id="P32">CONTACT FOR REAGENT AND RESOURCE SHARING</p></list-item><list-item><p id="P33">EXPERIMENTAL MODEL AND SUBJECT DETAILS</p><list list-type="simple" id="L2"><list-item><label>&#x025cb;</label><p id="P34">Cell culture and experimental conditions</p></list-item><list-item><label>&#x025cb;</label><p id="P35">Cell lines used in this study</p></list-item><list-item><label>&#x025cb;</label><p id="P36">GST-BHMT and GST<sub>LSCS</sub>GFP autophagy assays</p></list-item><list-item><label>&#x025cb;</label><p id="P37">GST<sub>LSCS</sub>GFP-ActA mitophagy assay</p></list-item><list-item><label>&#x025cb;</label><p id="P38">LC3-II flux autophagy assay</p></list-item><list-item><label>&#x025cb;</label><p id="P39">LC3B and WIPI2 immunofluorescence</p></list-item><list-item><label>&#x025cb;</label><p id="P40">Live-cell confocal microscopy</p></list-item><list-item><label>&#x025cb;</label><p id="P41">Cell transfections of plasmids or siRNA</p></list-item><list-item><label>&#x025cb;</label><p id="P42">Complex I Enzyme Activity</p></list-item><list-item><label>&#x025cb;</label><p id="P43">Mitochondrial DNA content</p></list-item><list-item><label>&#x025cb;</label><p id="P44">Liposome preparation</p></list-item><list-item><label>&#x025cb;</label><p id="P45">Percoll density separation of mitochondria population</p></list-item><list-item><label>&#x025cb;</label><p id="P46">Quantitative Real-Time PCR</p></list-item><list-item><label>&#x025cb;</label><p id="P47">Lysosomal pH</p></list-item><list-item><label>&#x025cb;</label><p id="P48">Glycogen measurements</p></list-item><list-item><label>&#x025cb;</label><p id="P49">NAD+/NADH measurements</p></list-item><list-item><label>&#x025cb;</label><p id="P50">High performance liquid chromatography (HPLC) analysis of
nucleotides</p></list-item><list-item><label>&#x025cb;</label><p id="P51">Proximity ligation assay (PLA) for MAMs</p></list-item><list-item><label>&#x025cb;</label><p id="P52">NMR Metabolomics analysis d</p></list-item></list></list-item><list-item><p id="P53">QUANTIFICATION AND STATISTICAL ANALYSIS</p><list list-type="simple" id="L3"><list-item><label>&#x025cb;</label><p id="P54">NMR Metabolomics Data analysis</p></list-item></list></list-item><list-item><p id="P55">DATA AND SOFTWARE AVAILABILITY</p></list-item></list><sec id="S19"><title>KEY RESOURCES TABLE</title><table-wrap id="T1" position="anchor" orientation="portrait"><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">REAGENT or RESOURCE</th><th align="left" valign="top" rowspan="1" colspan="1">SOURCE</th><th align="left" valign="top" rowspan="1" colspan="1">IDENTIFIER</th></tr><tr><th colspan="3" align="left" valign="top" rowspan="1"><hr/></th></tr></thead><tbody><tr><td colspan="3" align="left" valign="top" rowspan="1">Antibodies</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal pACC (Ser79)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 11818; RRID: AB_2687505</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal pS6K1 (Thr389)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 9234; RRID: AB_2269803</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal p4EBP1 (Ser65)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 9456; RRID: AB_823413</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal PARP</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 9542; RRID: AB_2160739</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal beta-actin</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 3700; RRID: AB_2242334</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal Myc-Tag (9B11)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 2276; RRID: AB_331783</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal pULK1 (Ser757)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 6888; RRID: AB_10829226</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal OPA1 (D6U6N)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 80471; RRID: AB_2734117</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal pAMPKa (Thr172)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 2535; RRID: AB_331250</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal TFAM (D5C8)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 80761; RRID: AB_10949110</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal PI3 Kinase Class III
(D9A5)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 4263; RRID: AB_2299765</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal ATG14 (D1A1N)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 96752</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal ATG13 (D4P1K)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 13273</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal ATG101 (E1Z4W)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 13492</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal ULK1 (D8H5)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 8054; RRID: AB_11178668</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Monoclonal ULK1 (D9D7)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 6439; RRID: AB_11178933</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal Beclin-1 (2A4)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 4122; RRID: AB_11178656</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal PARKIN Ab</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling Technology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 4211; RRID: AB_2159920</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal S6K</td><td align="left" valign="top" rowspan="1" colspan="1">BD Transduction Laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 611261; RRID: AB_398791</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal GST (B-14)</td><td align="left" valign="top" rowspan="1" colspan="1">Santa Cruz Biotechnology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# sc-138; RRID: AB_627677</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal TOM20 (F-10)</td><td align="left" valign="top" rowspan="1" colspan="1">Santa Cruz Biotechnology</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# sc-17764; RRID: AB_628381</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Anti-p62 lck ligand
(SQSTM1)</td><td align="left" valign="top" rowspan="1" colspan="1">BD Biosciences</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 610832; RRID: AB_398151</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal LC3B</td><td align="left" valign="top" rowspan="1" colspan="1">Novus Biologicals</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# NB100&#x02013;2220; RRID:
AB_10003146</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal LC3B</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# ab51520; RRID: AB_881429</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal PINK1</td><td align="left" valign="top" rowspan="1" colspan="1">Novus Biologicals</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# BC100&#x02013;494; RRID:
AB_10127658</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal RB1CC1 (FIP200)</td><td align="left" valign="top" rowspan="1" colspan="1">Novus Biologicals</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# NB100&#x02013;77279; RRID:
AB_1085475</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal RRBP1</td><td align="left" valign="top" rowspan="1" colspan="1">Bethyl</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A303&#x02013;996A; RRID:
AB_2620345</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal VDAC1</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# ab14734; RRID: AB_443084</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal IP3 Receptor</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# ab5804; RRID: AB_305124</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal anti-FLAG M2</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# F1804; RRID: AB_262044</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mouse Monoclonal Cytochrome Oxidase
Subunit II (COX II)</td><td align="left" valign="top" rowspan="1" colspan="1">Molecular Probes</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A6404; RRID: AB_221584</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CoralHue Keima-Red Mouse Monoclonal
Antibody</td><td align="left" valign="top" rowspan="1" colspan="1">MBL International</td><td align="left" valign="top" rowspan="1" colspan="1">Item# M126&#x02013;3M 013; RRID:
AB_843710</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rabbit Polyclonal WIPI2 antibody</td><td align="left" valign="top" rowspan="1" colspan="1">Invitrogen</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# PA5&#x02013;54098; RRID:
AB_2649654</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Goat anti-rabbit IgG, Alexa Fluor 488
secondary antibody</td><td align="left" valign="top" rowspan="1" colspan="1">Invitrogen</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A11008; RRID: AB_143165</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Goat anti-mouse IgG, Alexa Fluor 680
secondary antibody</td><td align="left" valign="top" rowspan="1" colspan="1">Invitrogen</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A21057; RRID: AB_2535723</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IRDye 680RD Goat anti-mouse</td><td align="left" valign="top" rowspan="1" colspan="1">LiCOR</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 926&#x02013;68070; RRID:
AB_10956588</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IRDye 800 CW Goat anti-rabbit</td><td align="left" valign="top" rowspan="1" colspan="1">LiCOR</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 926&#x02013;32211; RRID:
AB_621843</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Chemicals, Peptides, and
Recombinant Proteins</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Everolimus (RAD001)</td><td align="left" valign="top" rowspan="1" colspan="1">LC laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# E4040</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NVP-BEZ235</td><td align="left" valign="top" rowspan="1" colspan="1">LC laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# N4288</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Phenformin hydrochloride (P)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# P7045</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dextrose (Gluc)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# D9434</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">D-Galactose (Gal)</td><td align="left" valign="top" rowspan="1" colspan="1">Calbiochem</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CAS 59&#x02013;23-4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L-Aspartic acid (Asp)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A7219</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L-Glutamine (Gln)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# G8540</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L-Serine</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# S4311</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">D-Trehalose dihydrate (Treh)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# T0167</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adenosine</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A4036</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nicotinamide (NM)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# N0636</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FK866 hydrochloride hydrate (FK)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# F8557</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carbonyl cyanide
3-chlorophenyl-hydrazone (CC)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# C2759</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chloroquine diphosphate salt (CQ)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# C6628</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1,1-Dimethylbiguanide hydrochloride
(Metformin) (M)</td><td align="left" valign="top" rowspan="1" colspan="1">Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# D15,095&#x02013;9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ethanolamine (ETN)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 15014</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Uridine</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# U3003</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydroxylamine solution</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 467804</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antimycin A</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A8674</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oligomycin A</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 75351</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rotenone</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# R-8875</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Leupeptin hemisulfate</td><td align="left" valign="top" rowspan="1" colspan="1">Bacham</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# N-1000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">E64d</td><td align="left" valign="top" rowspan="1" colspan="1">Bacham</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# N-1650</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vinblastine (Vin)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# V1377</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nocodozole (Noc)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# M1404</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bafilomycin A1 (Baf)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# B1793</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin hydrochloride</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# PHR1789</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Percoll</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# P1644</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L-alpha-phosphatidylserine (PS)</td><td align="left" valign="top" rowspan="1" colspan="1">Avanti</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 840032C</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L-alpha-phosphatidylcholine (PC)</td><td align="left" valign="top" rowspan="1" colspan="1">Avanti</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 840051C</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L-alpha-phosphatidylethanolamine
(PE)</td><td align="left" valign="top" rowspan="1" colspan="1">Avanti</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 841118C</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Critical Commercial
Assays</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RNeasy Mini Kit</td><td align="left" valign="top" rowspan="1" colspan="1">QIAGEN</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 74104</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DNeasy Blood &#x00026; Tissue Kit</td><td align="left" valign="top" rowspan="1" colspan="1">QIAGEN</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 69506</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">QuantiNova SYBR Green PCR Kit</td><td align="left" valign="top" rowspan="1" colspan="1">QIAGEN</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 208052</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RT2 qPCR Primer Assay (ACTIN, PISD,
TFAM,<break/>PPARG1alpha, and NRF1)</td><td align="left" valign="top" rowspan="1" colspan="1">QIAGEN</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 330001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SuperScript III First-Strand Synthesis
SuperMix for qRT-PCR</td><td align="left" valign="top" rowspan="1" colspan="1">Invitrogen</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 11752&#x02013;050</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fast SYBR Green Master Mix</td><td align="left" valign="top" rowspan="1" colspan="1">Applied Biosystems</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 4385612</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duolink In Situ PLA Probe Anti-Rabbit
PLUS</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# DUO92002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duolink In Situ PLA Probe Anti-Mouse
MINUS</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# DUO92004</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duolink In Situ Detection Reagents
Red</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma-Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# DUO92008</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mitochondria Isolation Kit for
Cultured Cells</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# ab110170</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Complex I Enzyme Activity Microplate
Assay Kit</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# ab109721</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Glycogen Assay Kit</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# ab65620</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NAD/NADH Quantitation Colorimetric
Kit</td><td align="left" valign="top" rowspan="1" colspan="1">BioVision</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# K337</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LysoSensor Yellow/Blue Dextran</td><td align="left" valign="top" rowspan="1" colspan="1">Molecular Probes</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# L22460</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lipofectamine 3000 transfection
kit</td><td align="left" valign="top" rowspan="1" colspan="1">Invitrogen</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# L3000015</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FuGENE 6 transfection reagent</td><td align="left" valign="top" rowspan="1" colspan="1">Promega</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# E2691</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pierce glutathione agarose</td><td align="left" valign="top" rowspan="1" colspan="1">Thermo Scitific</td><td align="left" valign="top" rowspan="1" colspan="1">Prod# 16100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vectashield mounting medium with
DAPI</td><td align="left" valign="top" rowspan="1" colspan="1">Vector Laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# H-1200</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RIPA lysis buffer</td><td align="left" valign="top" rowspan="1" colspan="1">EMD Millipore</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 20&#x02013;188</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Deposited Data</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NMR and LIpidomics data</td><td align="left" valign="top" rowspan="1" colspan="1">This paper</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17632/ccx58pdy3d.1">https://doi.org/10.17632/ccx58pdy3d.1</ext-link></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Experimental Models: Cell
Lines</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293 (human, embryonic kidney)</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat#
CRL-1573,<break/>RRID:CVCL_0045</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293T (human, embryonic kidney)</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of Michael T Ryan</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R77" ref-type="bibr">Stroud et al., 2016</xref>)<break/>RRID:CVCL_0063)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293T NDUFA1 KO</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of Michael T Ryan</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R77" ref-type="bibr">Stroud et al., 2016</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293T NDUFA10 KO</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of Michael T Ryan</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R77" ref-type="bibr">Stroud et al., 2016</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293T NDUFS4 KO</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of Michael T Ryan</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R77" ref-type="bibr">Stroud et al., 2016</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293T NDUFS6 KO</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of Michael T Ryan</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R77" ref-type="bibr">Stroud et al., 2016</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293 TOMM20-Keima</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of J. Wade Harper</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R2" ref-type="bibr">An and
Harper, 2018</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293 TOMM20-Keima with PARKIN
overexpression</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of J. Wade Harper</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R2" ref-type="bibr">An and
Harper, 2018</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293 Mito-Keima</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of J. Wade Harper</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R2" ref-type="bibr">An and
Harper, 2018</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293T Flag-RAPTOR</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of G. Thomas</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEK293T Flag-RAPTOR-RHEB15</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of G. Thomas</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A549 (human, male, lung epithelial
carcinoma)</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat#
CCL-185,<break/>RRID:CCVL_0023</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hep3b (human, male, hepatocellular
carcinoma)</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat#
HB-8064.<break/>RRIC:CCVL_0326</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H9C2 (2&#x02013;1) (rat,
embryonic)</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat#
CRL-1446,<break/>RRID:CVCL_286</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Oligonucleotides</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FlexiTube siRNA Hs_PISD_6</td><td align="left" valign="top" rowspan="1" colspan="1">QIAGEN</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# SI04201750</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sense
5&#x02019;-GCGUCGUGUGACUCCUUCATT-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti
5&#x02019;-UGAAGGAGUCACACGACGCGG-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FlexiTube siRNA Hs_PISD_7</td><td align="left" valign="top" rowspan="1" colspan="1">QIAGEN</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# SI04249182</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sense
5&#x02019;-GAUUAAUGAUACAGACCUUTT-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti
5&#x02019;-AAGGUCUGUAUCAUUAAUCAG-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GAPDH gDNA</td><td align="left" valign="top" rowspan="1" colspan="1">IDT</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R64" ref-type="bibr">Prabhu et al., 2013</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Forward
5&#x02019;-CCCCACACACATGCACTTACC-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reverse
5&#x02019;-CCTAGTCCCAGGGCTTTGATT-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">b-Actin gDNA</td><td align="left" valign="top" rowspan="1" colspan="1">IDT</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R64" ref-type="bibr">Prabhu et al., 2013</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Forward
5&#x02019;-TCACCCACACTGTGCCCATGTACGA-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reverse
5&#x02019;-CAGCGGAACCGCTCATTGCCAATGG-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ATPase8 mtDNA</td><td align="left" valign="top" rowspan="1" colspan="1">IDT</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="R64" ref-type="bibr">Prabhu et al., 2013</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Forward
5&#x02019;-AATATTAAACACAAACTACCACCTACC-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reverse
5&#x02019;-TGGTTCTCAGGGTTTGTTATA-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">hCytochrome b mtDNA</td><td rowspan="3" align="left" valign="top" colspan="1">IDT</td><td rowspan="3" align="left" valign="top" colspan="1">(<xref rid="R52" ref-type="bibr">Morita et al., 2013</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Forward
5&#x02019;-GCGTCCTTGCCCTATTACTATC-3&#x02019;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reverse
5&#x02019;-CTTACTGGTTGTCCTCCGATTC-3&#x02019;</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Recombinant DNA</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GST-BHMT-IRES-GFPmyc (pRK5)</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of C. Mercer and P.
Dennis</td><td align="left" valign="top" rowspan="1" colspan="1">Addgene plasmid #104442</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GSTLCSCGFP-ActA (pRK5)</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of C. Mercer and P.
Dennis</td><td align="left" valign="top" rowspan="1" colspan="1">Addgene plasmid #104452</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GSTLCSCGFP (pRK5)</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory of C. Mercer and P.
Dennis</td><td align="left" valign="top" rowspan="1" colspan="1">Addgene plasmid #104451</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FLAG-RAPTOR (pLJM1)</td><td align="left" valign="top" rowspan="1" colspan="1">A gift from D. Sabatini</td><td align="left" valign="top" rowspan="1" colspan="1">Addgene plasmid #26633</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FLAG-RAPTOR-RHEB15 (pLJM1)</td><td align="left" valign="top" rowspan="1" colspan="1">A gift from D. Sabatini</td><td align="left" valign="top" rowspan="1" colspan="1">Addgene plasmid #26634</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1">Software and
Algorithms</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fiji ImageJ</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link></td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GraphPad Prism 7</td><td align="left" valign="top" rowspan="1" colspan="1">GraphPad software</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Topspin 3.1, Bruker Analytik,
Rhenstetten, Germany</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="https://www.bruker.com/products/mr/nmr/nmr-software/nmr-software/topspin/overview.html">https://www.bruker.com/products/mr/nmr/nmr-software/nmr-software/topspin/overview.html</ext-link></td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chenomx NMR Suite profiling software,
Chenomx Inc.<break/>version 8.1</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="https://www.chenomx.com/">https://www.chenomx.com/</ext-link></td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr></tbody></table></table-wrap></sec><sec id="S20"><title>CONTACT FOR REAGENT AND RESOURCE SHARING</title><p id="P56">Further information and requests for resources and reagents should be
directed to and will be fulfilled by the Lead Contact, Carol A. Mercer
(<email>mercerc@ucmail.uc.edu</email>).</p></sec><sec id="S21"><title>EXPERIMENTAL MODEL AND SUBJECT DETAILS</title><sec id="S22"><title>Cell culture and experimental conditions</title><p id="P57">All cells were cultured at 37&#x000b0;C, in 5% CO<sub>2,</sub> in
DMEM containing essential and non-essential amino acids, 4 mM glutamine, 1
mM sodium pyruvate, and 10% fetal calf serum (FCS). Experiments with glucose
or amino acid starvation, galactose, or trehalose contained FCS dialyzed
extensively against 25 mM HEPES pH 7.3, 50 mM NaCl, using Spectra/Por
membrane with MWCO 3500 (Spectrum Labs).</p></sec><sec id="S23"><title>Cell lines used in this study</title><list list-type="bullet" id="L4"><list-item><p id="P58">HEK293 cells (human, sex unknown, embryonic kidney, ATCC
CRL-1573, RRID:CVCL_0045)</p></list-item><list-item><p id="P59">HEK293 Keima knock-in cells were generously provided by J.
Wade Harper (<xref rid="R2" ref-type="bibr">An and Harper,
2018</xref>).</p></list-item><list-item><p id="P60">HEK293T cells (human, sex unknown, embryonic kidney,
RRID:CVCL_0063)</p></list-item><list-item><p id="P61">HEK293T cells with genetic deletion of
<italic>NDUFA1</italic>, <italic>NDUFA10</italic>,
<italic>NDUFS4</italic> and <italic>NDUFS6</italic> were
cultured in DMEM supplemented 50 &#x003bc;g/ml uridine. Uridine was
added to DMEM for both HEK293T parental and KO cells under
experimental conditions. These cells were generously provided by
Michael T. Ryan (<xref rid="R77" ref-type="bibr">Stroud et al.,
2016</xref>).</p></list-item><list-item><p id="P62">For experiments in HEK293T cells that stably express
Flag-RAPTOR and Flag-RAPTOR-RHEB15, cell media was refreshed with a
half media change 6 h before treatment. At time zero, cells were
placed in DMEM with 25 mM glucose, 1 mM pyruvate and 4 mM glutamine,
but without essential amino acids or serum for 60 minutes. For amino
acid stimulation, a mix of essential amino acids (EAA) was added
during the last 10 minutes, for final EAA concentrations equal to 1x
DMEM.</p></list-item><list-item><p id="P63">A549 cells (human, male, lung epithelial carcinoma, ATCC
CCL-185, RRID:CVCL_0023)</p></list-item><list-item><p id="P64">Hep3b cells (human, male, hepatocellular carcinoma, ATCC
HB-8064, RRID:CVCL_0326)</p></list-item><list-item><p id="P65">H9C2 (2&#x02013;1) cells (rat, embryonic myoblast, ATCC
CRL-1446, RRID:CVCL_286)</p></list-item></list></sec><sec id="S24"><title>GST-BHMT and GST<sub>LSCS</sub>GFP autophagy assays</title><p id="P66">The GST-BHMT and GST<sub>LSCS</sub>GFP assays were performed as
previously described (<xref rid="R15" ref-type="bibr">Dennis and Mercer,
2009</xref>; <xref rid="R49" ref-type="bibr">Mercer et al.,
2008</xref>). In brief, cells expressing GST-BHMT-IRES-GFPmyc,
GST<sub>LSCS</sub>GFP, or GST<sub>LSCS</sub>GFP-ActA were cultured for
the times indicated, with drugs or treatments as described. 5 nM RAD001 and
20 nM BEZ235 served as a positive control to induce autophagy/mitophagy.
Leupeptin (11 &#x003bc;M) and E64d (6 &#x003bc;M) were added at the beginning
of each treatment. The following steps were performed on ice or at
4&#x000b0;C. Except for <xref rid="SD1" ref-type="supplementary-material">Figure S4B</xref>, which were harvested for light membrane fractions
(LMFs) or unless otherwise indicated in the Figure panel, cells were
harvested in extraction buffer (EB) with 1% Triton X-100 (EB-TX) (50 mM
TRIS-HCl pH 8, 120 mM NaCl, 5 mM NaPPI, 10 mM NaF, 30 mM
para-nitrophenylphosphate, 1 mM benzamidine, 0.2% NP-40 and fresh 0.2 mM
PMSF). Total protein was determined by the Bradford method; and GST-BHMT was
precipitated with glutathione agarose from 300&#x02013;400 &#x003bc;g of cell
lysate. Bound GST-proteins were washed once in EB with 500 mM NaCl, and
1&#x02013;2 times in wash buffer (50 mM MOPS pH 7.5, 10 mM NaF, 30 mM
&#x003b2;-gycerolphosphate, 1 mM DTT, 0.1% Triton X-100, 10% glycerol).
Precipitates were boiled in SDS-PAGE sample buffer, eluted, resolved by
SDS-PAGE, followed by western blotting and imaging with the Odyssey system.
Whole cell lysates (25&#x02013;30 &#x003bc;g) were resolved by SDS-PAGE,
followed by western blotting and imaging with the Odyssey system, and probed
for antibodies as described. Western blotting for GFP-myc, whose expression
is under the control of an internal ribosome entry site (IRES), was used to
normalize expression of the GST-BHMT-IRES-GFPmyc plasmid. The GST-BHMT
fragment and GFP myc densities were quantified using the LiCOR imaging
software, and the GST-BHMT frag/GFP ratio was calculated as an autophagy
index. Raw ratios are shown on all graphs, whereas the numerical autophagy
&#x0201c;index&#x0201d; is shown on western blots, with normalization to the
RB GST-BHMT frag/GFP ratio represented as 1.0.</p></sec><sec id="S25"><title>GST<sub>LSCS</sub>GFP-ActA mitophagy assay</title><p id="P67">The GST<sub>LSCS</sub>GFP-ActA mitophagy assay was performed as
previously described (<xref rid="R15" ref-type="bibr">Dennis and Mercer,
2009</xref>) from LMFs. All steps were performed on ice or at
4&#x000b0;C. PBS-washed cells were collected and centrifuged at 1000xg for 5
min; the cell pellet was suspended in 400&#x02013;500 &#x003bc;l
homogenization buffer (HB) (10 mM TRIS pH 7.5, 300 mM sucrose, 0.2 mM EDTA,
0.2 mM PMSF) and disrupted by Dounce homogenization for 10&#x02013;15
strokes. The homogenate was centrifuged at 540 xg and the supernatant was
collected. The homogenization step was repeated with the low speed pellet,
and the combined supernatant was centrifuged at 12,000 xg for 20 min to
separate the LMF in the pellet from the high-speed supernatant (HSS). The
LMF fraction was homogenized in EB-TX, LMF protein was determined by
Bradford method, and GST-tagged proteins were precipitated with glutathione
agarose from 50 or more ug of LMF extract. Bound GST proteins were washed,
boiled in SDS-sample buffer, eluted, resolved by SDS-PAGE and visualized as
described above. 10 &#x003bc;g of LMF extract was resolved by SDS-PAGE,
followed by western blotting for mitochondria and autolysosomal proteins as
described.</p></sec><sec id="S26"><title>LC3-II flux autophagy assay</title><p id="P68">Cells were pre-treated for 1h with drugs as described, then treated
with 100 &#x003bc;M chloroquine (CQ), and harvested after 40 minutes. The
time of harvest was based on preliminary time course studies to determine
the optimal time to capture differences between control and autophagy
inducing conditions. Cells were harvested in EB-TX, total protein was
determined by Bradford assay, and 25 &#x003bc;g of total extract was resolved
by SDS-PAGE, followed by western blotting for LC3, and other proteins as
described. For LC3-II rate analysis, cells were treated as described above
with drugs and CQ, and cells were harvested at time points as described. In
both assays, levels of LC3-II were normalized to ACTIN.</p></sec><sec id="S27"><title>LC3B and WIPI2 immunofluorescence</title><p id="P69">HEK293 cells were seeded on 35 mm coverslip collagen coated dishes
(MatTek), grown to ~65%&#x02013;70% confluency. For LC3B puncta, cells were
treated as described for the LC3-II flux assay. For WIPI2 puncta, cells were
treated for 2 h. Cells were washed with PBS, fixed with ice cold methanol,
rinsed x3 with PBS, permeabilized with 0.1% saponin in PBS, blocked with 1%
BSA, 0.1% saponin in PBS, and incubated for 1 h with Abcam anti-LC3B
antibody (1:5000), or anti-WIPI2 antibody (1:200), at 37C in a humidity
chamber. Cells were rinsed x3 with PBS, incubated with a goat anti-rabbit
Alexa Fluor 488 secondary antibody (1:1000) diluted in blocking solution,
rinsed, dried and coverslipped with mounting media. 6&#x02013;10 z stack
images were captured for each treatment, using a Zeiss Axio Observer Z1
inverted microscope, 63x oil immersion lens (1x zoom), connected to a Zeiss
LSM710 confocal, and analyzed with Fiji ImageJ (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link>).</p></sec><sec id="S28"><title>Live-cell confocal microscopy</title><p id="P70">HEK293 cells were seeded on 35 mm coverslip collagen coated dishes
(MatTek), cultured to ~60% confluency, and duplicate plates were treated for
~4 h with V, RB, P<sup>1</sup> or RBP<sup>1</sup>. Z stack images of live
cells were acquired with a Zeiss LSM710 confocal with a Zeiss Observer.Z1
stand and a Zeiss Plan-Apochromat 63x/1.4 objective with a stage incubator
maintained at 37&#x000b0;C. Mito-Keima fluorescence was measured from
600&#x02013;740nm upon excitation with a 458nm or 561nm laser respectively.
Images were analyzed with Fiji ImageJ (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link>). Experiment was performed a minimum
of 2 times.</p></sec><sec id="S29"><title>Cell transfections of plasmids or siRNA</title><p id="P71">The optimal method for transfection of each cell line was determined
experimentally. HEK293 and 293T cells were transfected by the calcium
phosphate method (<xref rid="R10" ref-type="bibr">Chen and Okayama,
1988</xref>), using sterile filtered 2X BBS (50 mM BES, 280 mM NaCl, 1.5
mM Na<sub>2</sub>HPO<sub>4</sub>) pH ~7 and 20X 2.5 M CaCl<sub>2</sub>
prepared in house. A549 and H9c2 cells were transfected with Lipofectamine
3000, and Hep3b cells with Fugene 6, following manufacturers&#x02019;
protocols.</p></sec><sec id="S30"><title>Complex I Enzyme Activity</title><p id="P72">Mitochondrial complex I activity was measured using the Abcam
Complex I Enzyme Activity Kit (ab109721) per manufacturer&#x02019;s
directions. HEK293 cells were seeded at ~5.5 3 10<sup>6</sup> cells per 15
cm dish (n = 16) to reach ~70% confluency at 48 h. Cells were then treated
for a minimum of 16 h with V, P<sup>1</sup>, RB or RBP<sup>1</sup> (4 plates
each). At harvest time, cells were washed twice with ice cold PBS, scraped
into PBS, and pelleted at 1000 xg. 5% was reserved for further protein
analysis, and the remainder was used for isolation of mitochondria, using
either the LMF protocol, or Abcam Mitochondria Isolation Kit. Purified
mitochondria were suspended in 500 &#x003bc;l Buffer C and lysed for 30 min
with detergent (1% lauryl maltoside, final concentration). After
centrifugation, mitochondrial protein was quantified by Bradford and
mitochondrial lysates were adjusted to the same mg/ml concentration. Serial
dilutions were prepared in incubation solution (Abcam CI Assay Kit). Complex
I activity in 200 &#x003bc;l was measured on serial dilutions, each in
triplicate, per manufacture&#x02019;s protocol, using a Molecular Devices
VERSAmax microplate reader at 450nm, with kinetic readings taken every 30 s
for 30 minutes. Activity is represented as mOD/min. The assay shown is
representative of 4 independent experiments, with 2 or more dilutions.</p></sec><sec id="S31"><title>Mitochondrial DNA content</title><p id="P73">Mitochondrial DNA content was determined using a quantitative
real-time PCR approach, as described (<xref rid="R85" ref-type="bibr">Venegas and Halberg, 2012</xref>). In brief, 10 sets of HEK293 cells
were treated for 24h with V, RB, P<sup>1</sup>, and RBP. Total DNA from each
plate was isolated using the QIAGEN DNeasy Blood and Tissue Kit according to
manufacturer&#x02019;s protocol, and quantified using a NanoDrop 2000c
(Thermo Scientific). Four random sets of DNA were selected for qPCR on an
Applied Biosystems 7500 Fast Real-Time PCR System, using Fast SYBR Green
Master Mix, and 2 nuclear (n) primer sets against <italic>nGAPDH</italic>
and <italic>nACTIN</italic> and 2 mitochondrial (mt) primer sets against
mt<italic>ATPase8</italic> and mt<italic>CYTOCHROME b</italic> (<xref rid="R52" ref-type="bibr">Morita et al., 2013</xref>; <xref rid="R64" ref-type="bibr">Prabhu et al., 2013</xref>) (See <xref rid="T1" ref-type="table">Key Resources Table</xref>). Ct values were determined for each
sample in quadruplicate, and &#x00394;Ct values were determined for each
nuclear-mitochondria pair (n<italic>GAPDH</italic> Ct &#x02013;
mt<italic>Cytb</italic> Ct) and (n<italic>ACTIN</italic> Ct &#x02013;
mt<italic>ATPase8</italic> Ct). Mitochondrial DNA content for each
nuclear-mitochondria pair was determined using the formula
2&#x000d7;2(&#x00394;Ct), and averaged. The experiment was repeated using 4
additional sets of DNA.</p></sec><sec id="S32"><title>Liposome preparation</title><p id="P74">Liposomes were prepared with L-&#x003b1;-phosphatidylserine (PS)
(brain, porcine), L-&#x003b1;-phosphatidylcholine (PC) (egg, chicken), and
L-a-phosphatidylethanolamine (PE) (egg, chicken), each initially obtained as
a 10 mg/mL stock solution in chloroform (CHCl<sub>3</sub>). Suspensions of
liposomes in HEPES buffered saline (HBS) (20 mM HEPES, 100 mM NaCl, pH 7.4)
with total lipid concentrations of 1 mM were prepared with variable molar
ratios of PC, PS, and PE: (a) 8:2:0 PC/PS/PE (mol/mol/mol), (b) 6:2:2
PC/PS/PE (mol/mol/mol), or (c) 4:2:4 PC/PS/PE (mol/mol/mol). The lipid
solutions in CHCl<sub>3</sub> were mixed and then dried under
Ar<sub>(g)</sub>. HBS was added to the dried lipid film, incubated (1 h,
22&#x000b0;C), and vortexed (3 3 30 s, 22&#x000b0;C). The diameter of the
resultant liposomes was reduced by sequential extrusion through a 200-nm and
100-nm polycarbonate membrane filters (Avanti Cat #s 610006 and 610005). The
liposomes were briefly stored on ice prior to use.</p></sec><sec id="S33"><title>Percoll density separation of mitochondria population</title><p id="P75">Crude mitochondria were isolated and separated by density as
previously described (<xref rid="R89" ref-type="bibr">Wieckowski et al.,
2009</xref>). Starting number of HEK293 cells was ~150&#x02013;200
&#x000d7; 10<sup>6</sup> per treatment group, following 4 h treatments as
described in text. Briefly, cells were washed and collected in PBS,
disrupted by dounce homogenization in buffer (225 mM mannitol, 75 mM
sucrose, 0.1 mM EGTA, 30 mM Tris-HCL pH 7.4), and crude mitochondria were
isolated by multiple centrifugation steps. Mitochondria protein
concentrations were measured by Bradford. 2 mg of mitochondria protein were
loaded on a 30% Percoll gradient and centrifuged in an SW-41 rotor for 35
min, 95,000 g, to separate mitochondria into light and dense fractions. Each
fraction was collected, diluted in mitochondria resuspending buffer (250 mM
mannitol, 5 mM HEPES (pH 7.4) and 0.5 mM EGTA), and centrifuged at 6,300 g
for 10 min. Pellets were washed, recentrifuged as before, and resuspended in
equal volumes. 10 ug of crude mitochondria and a percentage of recovered
fractions were separated by SDS-PAGE, with western blotting for proteins as
shown.</p></sec><sec id="S34"><title>Quantitative Real-Time PCR</title><p id="P76">RNA was isolated from triplicate plates of HEK293 cells transfected
with siNS, siPISD-6 and siPISD-7, using the QIAGEN RNeasy kit per
manufacturer&#x02019;s instructions. For qRT-PCR of PGC1a, NRF1 and TFAM,
HEK293 cells were treated for 24 h with V, RB, P<sup>1</sup>, or
RBP<sup>1</sup>, prior to RNA isolation. 500 ng of total RNA was used
for reverse transcription using Invitrogen Superscript III First Strand
Synthesis SuperMix. mRNA gene expression was determined using QuantiNova
SYBR Green PCR Kit on the Applied Biosystems 7500 Fast Real-Time PCR System,
per manufacturer&#x02019;s instructions, with normalization to ACTIN.
RT<sup>2</sup> qPCR primer assays for ACTIN, PISD, NRF1, PPARG&#x003b1;
(PGC1&#x003b1;), and TFAM used in qRT-PCR reactions were purchased from
QIAGEN.</p></sec><sec id="S35"><title>Lysosomal pH</title><p id="P77">Lysosomal pH was measured using LysoSensor Yellow/Blue dextran
(Molecular Probes) per recommended protocol. HEK293 cells were treated for
~4.5 h with V, RB, P<sup>1</sup>, or RBP<sup>1</sup>. Cells were washed with
PBS, trypsinized, centrifuged and resuspended in DMEM. Cells were counted
using Trypan Blue and the Invitrogen Countess Cell Counting chamber system
and adjusted to 1 &#x000d7; 10^6 cells/ml. 1 mL cell aliquots were pelleted
by centrifugation, and pellets were resuspended in ~50 &#x003bc;l residual
DMEM. 50 &#x003bc;l of 2 mg/ml Yellow/ Blue dextran in DMEM was added to each
cell pellet for a final concentration of 1 mg/ml dextran, excluding a
no-dextran control, which received DMEM only. Cells were incubated for 2 h
at 37&#x000b0;C, 5% CO2, washed &#x000d7; 3 with Hank&#x02019;s buffered salt
solution (HBSS), and resuspended in 1 mL HBSS. Samples (100/well) were
loaded on a black 96-well plate (8 wells per each) and fluorescence was
monitored using a Clariostar microplate reader with emission wavelengths at
452 nm and 521 nm, and excitation at 335 nm. The ratio of emissions at
452/521 nm was calculated for each sample, and pH values were calculated
from a linear calibration curve. The calibration curve was generated by
incubating cells for 10 min at 37&#x000b0;C, prior to dextran loading, with
10 uM monensin and 10 uM nigericin in MES buffers (5 mM NaCl, 115 mM KCL,
1.3 mM MgSO4, 25 mM MES), with pHs ranging from 3.5 &#x02013; 7.0 (<xref rid="R17" ref-type="bibr">Diwu et al., 1999</xref>). r<sup>2</sup> =
0.913</p></sec><sec id="S36"><title>Glycogen measurements</title><p id="P78">3.5 &#x000d7; 10<sup>5</sup> HEK293 cells were plated in 6-well
dishes and grown to ~60%&#x02013;70% confluence. Cells were treated in
triplicate for 6 h with V, RB, P<sup>1</sup> or RBP<sup>1</sup>. Glycogen
measurements were performed in triplicate with 3 separate dilutions, using
Abcam&#x02019;s Glycogen Assay kit per manufacturer&#x02019;s instructions.
Glycogen levels were determined using a freshly prepared standard curve:
slope = 0.6074, r<sup>2</sup> = 0.9990.</p></sec><sec id="S37"><title>NAD+/NADH measurements</title><p id="P79">1.7 &#x000d7; 10<sup>5</sup> HEK293 cells were plated in 6-well
dishes and grown to ~50%&#x02013;60% confluence. Cells were treated in
duplicate for 6 h with V, RB, P<sup>1</sup>, RBP<sup>1</sup>, 5 mM NAM, 10
nM FK866, or RBP+NAM and harvested and analyzed for NADH and NAD+ using the
BioVision NAD/NADH Quantitation Colorimetric Kit per manufacturer&#x02019;s
instructions. In brief, cells were washed in cold PBS and scraped into 400
&#x003bc;l cold extraction buffer and disrupted by dounce homogenization (10
strokes), vortexed 10 s, and centrifuged at 4&#x000b0;C for 5 min. Half of
the supernatant was heated for 30 min at 60&#x000b0;C to decompose NAD,
leaving NADH intact (NADH), and quick spun to remove any precipitates. The
remaining half contained total NAD and NADH (NADt). 50 &#x003bc;l of each
undiluted sample (total or heated), and each sample diluted 1:2 and 1:4, was
immediately assayed in duplicate in 96-well format. NAD Cycling Mix (100
&#x003bc;l/well) was added, mixed and incubated for 5 min at RT to convert
NAD to NADH, and then 10 &#x003bc;l of NADH developer was added for
1&#x02013;4 h, and the plate was read at OD 450 nm after the reactions were
stopped with Stop Solution (10 &#x003bc;l). Ratios were calculated as NADH /
NADt &#x02013; NADH.</p></sec><sec id="S38"><title>High performance liquid chromatography (HPLC) analysis of
nucleotides</title><p id="P80">HEK293 cells were plated on 10cm dishes, treated as described in
text, and harvested at the times indicated in duplicate. Cells were rinsed 2
times with cold PBS, scraped into 1ml of 80% acetonitrile, and centrifuged
at 4&#x000b0;C for 5 min. Supernatants were heat shocked at 80&#x000b0;C for 3
min, speed vacuumed until dry, and rehydrated with 100&#x02013;200 &#x003bc;l
HPLC water. Following centrifugation, samples were analyzed by HPLC on a
Shimadzu LC-10AT <italic>VP</italic> system with a ZORBAX Extend-C18 column
(Agilent). Analyses were performed using a sample injection volume of 50
&#x003bc;l at room temperature (RT), a flowrate of 1.0 ml/min, and a linear
gradient program. Buffer A: 20 mM NaH<sub>2</sub>PO<sub>4</sub> pH 8.5 with
NaOH, 10 mM tetrabutyl ammonium hydrogen (TBA); Buffer B: 100 mM
NaH<sub>2</sub>PO<sub>4</sub> pH 3.0 with HCl, 10 mM TBA, 30% MeOH;
Buffer C: 30% MeOH. The HPLC program was: 0&#x02013;15 min, 0%B, 0%C; 20 min,
10%B, 0%C; 25min, 15%B, 0%C; 65min, 30%B, 0%C; 85 min, 60%B, 0%C; 95 min,
80%B, 0%C; 95.1 min, 0%B, 100%C; 120 min, 0%B, 100%C; 121 min, 0%B, 0%C; 130
min, stop. UV detection was set at 254 nm wavelength. Peaks were identified
by retention times and compared to the peak spectrum of authentic standards.
For ATP analysis in cells supplemented with adenosine, HPLC protocol was
modified as follows: (i) samples were injected at a volume of 60 ul; (ii)
Buffer C was not included, and (iii) program details were 0&#x02013;20 min,
0%B; 25 min, 15%B; 40 min, 55%B; 70 min, 30%B; 85 min, 60%B; 95 min, 80%B;
110 min, 80%B; 115 min, 0%B; 120 min, stop.</p></sec><sec id="S39"><title>Proximity ligation assay (PLA) for MAMs</title><p id="P81">The PLA for MAMs followed a previously described protocol (<xref rid="R82" ref-type="bibr">Tubbs and Rieusset, 2016</xref>) and the
DuoLink InSitu Detection Reagents Red kit instructions (Sigma).
1.3&#x02013;1.6 &#x000d7; 10<sup>5</sup> HEK293T and 1.5&#x02013;2.2 &#x000d7;
10<sup>5</sup>
<italic>NDUFA1</italic><sup>KO</sup> cells were seeded on 35 mm coverslip
collagen coated dishes (MatTek), cultured to ~60% confluency, and duplicate
plates were treated for 4h with V, RB, P<sup>1</sup> or RBP. Control plates
for no antibody or single antibodies were treated with V. Cells were washed
with PBS and fixed for 10 min at RT with fresh 4% formaldehyde solution in
PBS (Thermo Scientific Pierce, #28908), which was stopped by adding an equal
volume of 1M glycine. Cells were washed once with PBS, and incubated in 100
mM glycine for 15 min at RT, permeabilized with 0.1% Triton X-100 in PBS for
15 min at RT, washed once with PBS, and blocked for 30 min at 37&#x000b0;C in
a humidity chamber with blocking reagent (included in the DuoLink InSitu PLA
Probe kit). Anti-IP3R-1 (rabbit) and anti-VDAC1 (mouse) antibodies were
prepared at 1:500 and 1:100 dilutions respectively, and added to cells for
overnight incubation, in a humidity chamber at 4&#x000b0;C. Plates were
washed twice with TBS-Tween (0.01%) or DuoLink Fluorescent Wash buffer A,
then incubated for 1h at 37&#x000b0;C in a humidity chamber with DuoLink
InSitu PLA Probes, Anti-Rabbit Plus and Anti-Mouse Minus. The ligation and
amplification steps, with their incubation times, conditions, and wash steps
were performed per manufacturer&#x02019;s instructions. After the final
washes in 1x and 0.01x DuoLink Fluorescent Wash buffer B, plates were dried
and then mounted with round coverslips using aqueous mounting media with
DAPI (Vector Labs). A minimum of 10 z stack images were captured for each
cell line and treatment, using a Zeiss Axio Observer Z1 inverted microscope,
63x oil immersion lens (1x zoom), connected to a Zeiss LSM710 confocal and
analyzed with Fiji ImageJ (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link>). Images shown are maximal
projection images. Data are representative of 3 independent experiments in
WT and NDUF KO cells, and 2 independent experiments with glucose
starvation.</p></sec><sec id="S40"><title>Targeted phosphatidylethanolamine (PE) and Phosphatidylserine (PS)
analysis:</title><p id="P82">Quantitative analysis of PE and PS was carried out using a Waters
Premier XE triple quadrupole mass spectrometer interfaced with an Acquity
ultra-high performance liquid chromatography (UPLC) system (Waters, Milford,
MA). Mass spectrometer was operated in electrospray ionization mode with
negative ion acquisition. Phospholipids were extracted from cells by the
Folch procedure with initial addition of internal standards,
D<sub>31</sub>-160/181 PE and D<sub>31</sub>-160/181 PS. Quantification was
based on calibration curves constructed using PE and PS standards with
multiple reactions monitoring function. PE calibration curves include 160
LPE, 181 LPE, 160/181 PE, 160,182 PE, 180,182 PE, 180/204 ES. PE and PS
species without reference compounds were quantified with the standard
sharing the closest structure. PS calibration curves include 160 LPS, 181
LPS, 180 LPS, 160/181 PS, 160,182 PS, 180,182 PS, 180/204 PS. Final
concentration of PE and PS were normalized to DNA contents in the cell and
expressed as ng/mg DNA.</p></sec><sec id="S41"><title>NMR Metabolomics analysis</title><sec id="S42"><title>Sample processing</title><p id="P83">The hydrophilic cell extracts were dried in a SpeedVac
centrifuge for 4&#x02013;6 h at room temperature, and stored at
20&#x000b0;C until data collection. The dried polar extracts were
re-hydrated with 600 &#x003bc;L of NMR buffer containing 100 mM phosphate
buffer, pH 7.3, 1 mM TMSP (3-Trimethylsilyl 2,2,3,3-d4 propionate, CAS
24493&#x02013;21-8), and 1 mg/mL NaN3 (sodium azide CAS
26627&#x02013;22-8) prepared in D<sub>2</sub>O.</p><p id="P84">Media samples were thawed on ice and centrifuged 4000 &#x000d7;
g<sub>n</sub> for 5 min at 4&#x000b0;C. The 500 &#x003bc;L supernatant
of the media samples were aliquoted onto pre-washed 3 kDa spin filters
(NANOSEP 3K, Pall Life Sciences), and centrifuged 10000 &#x000d7;
g<sub>n</sub> for 90 min at 4&#x000b0;C. The 300 mL of media filtrate
was mixed with 300 &#x003bc;L of NMR buffer.</p></sec><sec id="S43"><title>NMR data collection</title><p id="P85">One-dimensional <sup>1</sup>H NMR spectra were recorded on all
samples using the nuclear overhauser spectroscopy (NOESY) pulse sequence
with presaturation of the water peak on a Bruker Avance II 600 MHz
spectrometer. Two-dimensional <sup>13</sup>C edited heteronuclear single
quantum correlation (HSQC) spectra for representative samples were
acquired to assess the metabolites annotation. All NMR data were
processed using Topspin 3.1 software (Bruker Analytik, Rheinstetten,
Germany). All FIDs were subjected to an exponential line-broadening of
0.3 Hz. Upon Fourier transformation, each spectrum was manually phased,
baseline corrected, and referenced to the internal standard TMSP at 0.0
ppm. Metabolites found in cell extract and media were assigned based on
1D <sup>1</sup>H and 2D NMR experiments with reference spectra found in
databases, such as the Human Metabolome Database and Chenomx &#x000ae;NMR
Suite profiling software (Chenomx Inc. version 8.1).</p></sec></sec></sec><sec id="S44"><title>QUANTIFICATION AND STATISTICAL ANALYSIS</title><p id="P86">Western blot analyses were quantified using the Li-Cor imaging system
software. All data, with the exception of NMR and targeted lipidomics, listed
separately below, are presented as mean &#x000b1; SD. Statistical analyzes
utilized GraphPad Prism 7, and statistical significance was determined using
one-way analysis of variance (ANOVA) with Turkey HSD (Honestly Significant
Difference) calculation to compare multiple treatments.</p></sec><sec id="S45"><title>NMR Metabolomics Data analysis</title><p id="P87"><sup>1</sup>H NMR spectra were processed and analyzed with AMIX for PCA
analysis and the spectral bucket intensity tables were generated for further
analysis. The spectra from 0.5 to 10.0 ppm, excluding the region of the residual
water resonance (4.6 to 5.0 ppm), methanol (3.36&#x02013;3.38 ppm), and
phenformin (3.49&#x02013;3.54, 7.29&#x02013;7.43ppm) were reduced by uniform
binning to 1916 buckets 0.005 ppm wide. The spectra were normalized to constant
total spectral area prior to PCA analysis and the binned spectra were
mean-centered with no scaling.</p><p id="P88">The metabolites assigned bin-by-bin differences between each group were
assessed by univariate approach. Pairwise differences within each bin were
compared using a two-tailed Welch&#x02019;s t test, the false discovery rate
(FDR) was controlled at the 0.05 level using the Benjamini-Hochberg method
(<xref rid="R4" ref-type="bibr">Benjamini and Hochberg, 1995</xref>).</p></sec><sec id="S46"><title>DATA AND SOFTWARE AVAILABILITY</title><p id="P89">The NMR and lipidomics datasets reported in this paper are available at
Mendeley Data: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17632/ccx58pdy3d.1">https://doi.org/10.17632/ccx58pdy3d.1</ext-link>.</p></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS1505951-supplement-1.pdf" orientation="portrait" xlink:type="simple" id="d36e2677" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>2</label><media xlink:href="NIHMS1505951-supplement-2.pdf" orientation="portrait" xlink:type="simple" id="d36e2681" position="anchor"/></supplementary-material></sec></body><back><ack id="S47"><title>ACKNOWLEDGMENTS</title><p id="P90">We would like to acknowledge the service and contributions of Drs. Wujuan
Zhang and Kenneth Setchell at the Mass Spectrometry Core Facility and Drs. Miki
Watanabe and Lindsey Romick-Rosendale in the NMR-based Metabolomics Core, both at
Cincinnati Children&#x02019;s Hospital. We thank Drs. Atsuo Sasaki and Yoshiki Ikeda
(UC Hem/Onc) for their assistance with HPLC measurement of nucleotides, Dr. Maria
Czyzyk-krzeska and Megan Bischoff (UC Department of Cancer Biology) for sharing
their protocol and expertise in LC3B immunofluorescence, and Dr. Birgit Ehmer (UC
Department of Cancer Biology Microscopy Laboratory) for her knowledge and assistance
with confocal microscopy. We also express our gratitude to Drs. Michael T. Ryan for
sharing the NDUF KO cell lines, Heeseon An and Wade Harper for sharing the Keima
mitophagy reporter cells, and Patrick Dennis for his critical reading of the
manuscript. This work was supported by funding from the National Cancer Institute
(R21CA191814) and the Hematology Oncology Translational Science and Pilot Grant
Award (HOTSA/HOTGA) program at the University of Cincinnati.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P91">DECLARATION OF INTERESTS</p><p id="P92">The authors declare no competing interests.</p></fn><fn id="FN3"><p id="P93">SUPPLEMENTAL INFORMATION</p><p id="P94">Supplemental Information includes seven figures and can be found with
this article online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2018.07.101">https://doi.org/10.1016/j.celrep.2018.07.101</ext-link>.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><mixed-citation publication-type="journal"><name><surname>Amaravadi</surname><given-names>RK</given-names></name>, <name><surname>Lippincott-Schwartz</surname><given-names>J</given-names></name>, <name><surname>Yin</surname><given-names>XM</given-names></name>, <name><surname>Weiss</surname><given-names>WA</given-names></name>, <name><surname>Takebe</surname><given-names>N</given-names></name>, <name><surname>Timmer</surname><given-names>W</given-names></name>, <name><surname>DiPaola</surname><given-names>RS</given-names></name>, <name><surname>Lotze</surname><given-names>MT</given-names></name>, and <name><surname>White</surname><given-names>E</given-names></name> (<year>2011</year>). <article-title>Principles and current strategies
for targeting autophagy for cancer treatment</article-title>. <source>Clin.
Cancer Res</source>
<volume>17</volume>,
<fpage>654</fpage>&#x02013;<lpage>666</lpage>.<pub-id pub-id-type="pmid">21325294</pub-id></mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><name><surname>An</surname><given-names>H</given-names></name>, and <name><surname>Harper</surname><given-names>JW</given-names></name> (<year>2018</year>). <article-title>Systematic analysis of ribophagy in
human cells reveals bystander flux during selective
autophagy</article-title>. <source>Nat. Cell Biol</source>
<volume>20</volume>,
<fpage>135</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="pmid">29230017</pub-id></mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><name><surname>Auciello</surname><given-names>FR</given-names></name>, <name><surname>Ross</surname><given-names>FA</given-names></name>, <name><surname>Ikematsu</surname><given-names>N</given-names></name>, and <name><surname>Hardie</surname><given-names>DG</given-names></name> (<year>2014</year>). <article-title>Oxidative stress activates AMPK in
cultured cells primarily by increasing cellular AMP and/or
ADP</article-title>. <source>FEBS Lett</source>. <volume>588</volume>,
<fpage>3361</fpage>&#x02013;<lpage>3366</lpage>.<pub-id pub-id-type="pmid">25084564</pub-id></mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name>, and <name><surname>Hochberg</surname><given-names>Y</given-names></name> (<year>1995</year>). <article-title>Controlling the False Discovery
Rate: A Practical and Powerful Approach to Multiple Testing</article-title>.
<source>J. R. Stat. Soc. B</source>
<volume>57</volume>,
<fpage>289</fpage>&#x02013;<lpage>300</lpage>.</mixed-citation></ref><ref id="R5"><mixed-citation publication-type="journal"><name><surname>Birsoy</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>T</given-names></name>, <name><surname>Chen</surname><given-names>WW</given-names></name>, <name><surname>Freinkman</surname><given-names>E</given-names></name>, <name><surname>Abu-Remaileh</surname><given-names>M</given-names></name>, and <name><surname>Sabatini</surname><given-names>DM</given-names></name> (<year>2015</year>). <article-title>An Essential Role of the
Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable
Aspartate Synthesis</article-title>. <source>Cell</source>
<volume>162</volume>,
<fpage>540</fpage>&#x02013;<lpage>551</lpage>.<pub-id pub-id-type="pmid">26232224</pub-id></mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><name><surname>Bov&#x000e9;</surname><given-names>J</given-names></name>, <name><surname>Mart&#x000ed;nez-Vicente</surname><given-names>M</given-names></name>, and <name><surname>Vila</surname><given-names>M</given-names></name> (<year>2011</year>). <article-title>Fighting neurodegeneration with
rapamycin: mechanistic insights</article-title>. <source>Nat. Rev.
Neurosci</source>
<volume>12</volume>,
<fpage>437</fpage>&#x02013;<lpage>452</lpage>.<pub-id pub-id-type="pmid">21772323</pub-id></mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><name><surname>Bravo-Sagua</surname><given-names>R</given-names></name>, <name><surname>L&#x000f3;pez-Crisosto</surname><given-names>C</given-names></name>, <name><surname>Parra</surname><given-names>V</given-names></name>, <name><surname>Rodriguez-Pe&#x00148;a</surname><given-names>M</given-names></name>, <name><surname>Rothermel</surname><given-names>BA</given-names></name>, <name><surname>Quest</surname><given-names>AF</given-names></name>, and <name><surname>Lavandero</surname><given-names>S</given-names></name> (<year>2016</year>). <article-title>mTORC1 inhibitor rapamycin and ER
stressor tunicamycin induce differential patterns of ER-mitochondria
coupling</article-title>. <source>Sci. Rep</source>
<volume>6</volume>, <fpage>36394</fpage>.<pub-id pub-id-type="pmid">27808250</pub-id></mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><name><surname>Buzzai</surname><given-names>M</given-names></name>, <name><surname>Bauer</surname><given-names>DE</given-names></name>, <name><surname>Jones</surname><given-names>RG</given-names></name>, <name><surname>Deberardinis</surname><given-names>RJ</given-names></name>, <name><surname>Hatzivassiliou</surname><given-names>G</given-names></name>, <name><surname>Elstrom</surname><given-names>RL</given-names></name>, and <name><surname>Thompson</surname><given-names>CB</given-names></name> (<year>2005</year>). <article-title>The glucose dependence of
Akttransformed cells can be reversed by pharmacologic activation of fatty
acid beta-oxidation</article-title>. <source>Oncogene</source>
<volume>24</volume>,
<fpage>4165</fpage>&#x02013;<lpage>4173</lpage>.<pub-id pub-id-type="pmid">15806154</pub-id></mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><name><surname>Calzada</surname><given-names>E</given-names></name>, <name><surname>Onguka</surname><given-names>O</given-names></name>, and <name><surname>Claypool</surname><given-names>SM</given-names></name> (<year>2016</year>). <article-title>Phosphatidylethanolamine Metabolism
in Health and Disease</article-title>. <source>Int. Rev. Cell Mol.
Biol</source>
<volume>321</volume>,
<fpage>29</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">26811286</pub-id></mixed-citation></ref><ref id="R10"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>CA</given-names></name>, and <name><surname>Okayama</surname><given-names>H</given-names></name> (<year>1988</year>). <article-title>Calcium phosphate-mediated gene
transfer: a highly efficient transfection system for stably transforming
cells with plasmid DNA</article-title>. <source>Biotechniques</source>
<volume>6</volume>,
<fpage>632</fpage>&#x02013;<lpage>638</lpage>.<pub-id pub-id-type="pmid">3273409</pub-id></mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><name><surname>Cheong</surname><given-names>H</given-names></name>, <name><surname>Lindsten</surname><given-names>T</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Lu</surname><given-names>C</given-names></name>, and <name><surname>Thompson</surname><given-names>CB</given-names></name> (<year>2011</year>). <article-title>Ammonia-induced autophagy is
independent of ULK1/ULK2 kinases</article-title>. <source>Proc. Natl. Acad.
Sci. USA</source>
<volume>108</volume>,
<fpage>11121</fpage>&#x02013;<lpage>11126</lpage>.<pub-id pub-id-type="pmid">21690395</pub-id></mixed-citation></ref><ref id="R12"><mixed-citation publication-type="journal"><name><surname>Corominas-Faja</surname><given-names>B</given-names></name>, <name><surname>Quirantes-Pin&#x000e9;</surname><given-names>R</given-names></name>, <name><surname>Oliveras-Ferraros</surname><given-names>C</given-names></name>, <name><surname>Vazquez-Martin</surname><given-names>A</given-names></name>, <name><surname>Cuf&#x000ed;</surname><given-names>S</given-names></name>, <name><surname>Martin-Castillo</surname><given-names>B</given-names></name>, <name><surname>Micol</surname><given-names>V</given-names></name>, <name><surname>Joven</surname><given-names>J</given-names></name>, <name><surname>Segura-Carretero</surname><given-names>A</given-names></name>, and <name><surname>Menendez</surname><given-names>JA</given-names></name> (<year>2012</year>). <article-title>Metabolomic fingerprint reveals that
metformin impairs one-carbon metabolism in a manner similar to the
antifolate class of chemotherapy drugs</article-title>. <source>Aging
(Albany N.Y.)</source>
<volume>4</volume>,
<fpage>480</fpage>&#x02013;<lpage>498</lpage>.</mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name><surname>Cunningham</surname><given-names>JT</given-names></name>, <name><surname>Rodgers</surname><given-names>JT</given-names></name>, <name><surname>Arlow</surname><given-names>DH</given-names></name>, <name><surname>Vazquez</surname><given-names>F</given-names></name>, <name><surname>Mootha</surname><given-names>VK</given-names></name>, and <name><surname>Puigserver</surname><given-names>P</given-names></name> (<year>2007</year>). <article-title>mTOR controls mitochondrial
oxidative function through a YY1-PGC-1alpha transcriptional
complex</article-title>. <source>Nature</source>
<volume>450</volume>,
<fpage>736</fpage>&#x02013;<lpage>740</lpage>.<pub-id pub-id-type="pmid">18046414</pub-id></mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name><surname>DeBosch</surname><given-names>BJ</given-names></name>, <name><surname>Heitmeier</surname><given-names>MR</given-names></name>, <name><surname>Mayer</surname><given-names>AL</given-names></name>, <name><surname>Higgins</surname><given-names>CB</given-names></name>, <name><surname>Crowley</surname><given-names>JR</given-names></name>, <name><surname>Kraft</surname><given-names>TE</given-names></name>, <name><surname>Chi</surname><given-names>M</given-names></name>, <name><surname>Newberry</surname><given-names>EP</given-names></name>, <name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Finck</surname><given-names>BN</given-names></name>, <etal/> (<year>2016</year>). <article-title>Trehalose inhibits solute
carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic
steatosis</article-title>. <source>Sci. Signal</source>
<volume>9</volume>, <fpage>ra21</fpage>.<pub-id pub-id-type="pmid">26905426</pub-id></mixed-citation></ref><ref id="R15"><mixed-citation publication-type="journal"><name><surname>Dennis</surname><given-names>PB</given-names></name>, and <name><surname>Mercer</surname><given-names>CA</given-names></name> (<year>2009</year>). <article-title>The GST-BHMT assay and related
assays for autophagy</article-title>. <source>Methods Enzymol</source>.
<volume>452</volume>,
<fpage>97</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">19200878</pub-id></mixed-citation></ref><ref id="R16"><mixed-citation publication-type="journal"><name><surname>Di Bartolomeo</surname><given-names>F</given-names></name>, <name><surname>Wagner</surname><given-names>A</given-names></name>, and <name><surname>Daum</surname><given-names>G</given-names></name> (<year>2017</year>). <article-title>Cell biology, physiology and
enzymology of phosphatidylserine decarboxylase</article-title>.
<source>Biochim. Biophys. Acta</source>
<volume>1862</volume>,
<fpage>25</fpage>&#x02013;<lpage>38</lpage>.</mixed-citation></ref><ref id="R17"><mixed-citation publication-type="journal"><name><surname>Diwu</surname><given-names>Z</given-names></name>, <name><surname>Chen</surname><given-names>CS</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Klaubert</surname><given-names>DH</given-names></name>, and <name><surname>Haugland</surname><given-names>RP</given-names></name> (<year>1999</year>). <article-title>A novel acidotropic pH indicator and
its potential application in labeling acidic organelles of live
cells</article-title>. <source>Chem. Biol</source>
<volume>6</volume>,
<fpage>411</fpage>&#x02013;<lpage>418</lpage>.<pub-id pub-id-type="pmid">10381401</pub-id></mixed-citation></ref><ref id="R18"><mixed-citation publication-type="journal"><name><surname>Egan</surname><given-names>DF</given-names></name>, <name><surname>Shackelford</surname><given-names>DB</given-names></name>, <name><surname>Mihaylova</surname><given-names>MM</given-names></name>, <name><surname>Gelino</surname><given-names>S</given-names></name>, <name><surname>Kohnz</surname><given-names>RA</given-names></name>, <name><surname>Mair</surname><given-names>W</given-names></name>, <name><surname>Vasquez</surname><given-names>DS</given-names></name>, <name><surname>Joshi</surname><given-names>A</given-names></name>, <name><surname>Gwinn</surname><given-names>DM</given-names></name>, <name><surname>Taylor</surname><given-names>R</given-names></name>, <etal/> (<year>2011</year>). <article-title>Phosphorylation of ULK1
(hATG1) by AMP-activated protein kinase connects energy sensing to
mitophagy</article-title>. <source>Science</source>
<volume>331</volume>,
<fpage>456</fpage>&#x02013;<lpage>461</lpage>.<pub-id pub-id-type="pmid">21205641</pub-id></mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name><surname>Farr&#x000e9;</surname><given-names>JC</given-names></name>, and <name><surname>Subramani</surname><given-names>S</given-names></name> (<year>2016</year>). <article-title>Mechanistic insights into selective
autophagy pathways: lessons from yeast</article-title>. <source>Nat. Rev.
Mol. Cell Biol</source>
<volume>17</volume>,
<fpage>537</fpage>&#x02013;<lpage>552</lpage>.<pub-id pub-id-type="pmid">27381245</pub-id></mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><name><surname>Gomes</surname><given-names>LC</given-names></name>, <name><surname>Di Benedetto</surname><given-names>G</given-names></name>, and <name><surname>Scorrano</surname><given-names>L</given-names></name> (<year>2011</year>). <article-title>During autophagy mitochondria
elongate, are spared from degradation and sustain cell
viability</article-title>. <source>Nat. Cell Biol</source>
<volume>13</volume>,
<fpage>589</fpage>&#x02013;<lpage>598</lpage>.<pub-id pub-id-type="pmid">21478857</pub-id></mixed-citation></ref><ref id="R21"><mixed-citation publication-type="journal"><name><surname>Graef</surname><given-names>M</given-names></name>, and <name><surname>Nunnari</surname><given-names>J</given-names></name> (<year>2011</year>). <article-title>Mitochondria regulate autophagy by
conserved signalling pathways</article-title>. <source>EMBO J</source>.
<volume>30</volume>,
<fpage>2101</fpage>&#x02013;<lpage>2114</lpage>.<pub-id pub-id-type="pmid">21468027</pub-id></mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>JY</given-names></name>, <name><surname>Teng</surname><given-names>X</given-names></name>, <name><surname>Laddha</surname><given-names>SV</given-names></name>, <name><surname>Ma</surname><given-names>S</given-names></name>, <name><surname>Van Nostrand</surname><given-names>SC</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Khor</surname><given-names>S</given-names></name>, <name><surname>Chan</surname><given-names>CS</given-names></name>, <name><surname>Rabinowitz</surname><given-names>JD</given-names></name>, and <name><surname>White</surname><given-names>E</given-names></name> (<year>2016</year>). <article-title>Autophagy provides metabolic
substrates to maintain energy charge and nucleotide pools in Ras-driven lung
cancer cells</article-title>. <source>Genes Dev</source>.
<volume>30</volume>,
<fpage>1704</fpage>&#x02013;<lpage>1717</lpage>.<pub-id pub-id-type="pmid">27516533</pub-id></mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><name><surname>Gwinn</surname><given-names>DM</given-names></name>, <name><surname>Shackelford</surname><given-names>DB</given-names></name>, <name><surname>Egan</surname><given-names>DF</given-names></name>, <name><surname>Mihaylova</surname><given-names>MM</given-names></name>, <name><surname>Mery</surname><given-names>A</given-names></name>, <name><surname>Vasquez</surname><given-names>DS</given-names></name>, <name><surname>Turk</surname><given-names>BE</given-names></name>, and <name><surname>Shaw</surname><given-names>RJ</given-names></name> (<year>2008</year>). <article-title>AMPK phosphorylation of raptor
mediates a metabolic checkpoint</article-title>. <source>Mol. Cell</source>
<volume>30</volume>,
<fpage>214</fpage>&#x02013;<lpage>226</lpage>.<pub-id pub-id-type="pmid">18439900</pub-id></mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name><surname>Hailey</surname><given-names>DW</given-names></name>, <name><surname>Rambold</surname><given-names>AS</given-names></name>, <name><surname>Satpute-Krishnan</surname><given-names>P</given-names></name>, <name><surname>Mitra</surname><given-names>K</given-names></name>, <name><surname>Sougrat</surname><given-names>R</given-names></name>, <name><surname>Kim</surname><given-names>PK</given-names></name>, and <name><surname>Lippincott-Schwartz</surname><given-names>J</given-names></name> (<year>2010</year>). <article-title>Mitochondria supply membranes for
autophagosome biogenesis during starvation</article-title>.
<source>Cell</source>
<volume>141</volume>,
<fpage>656</fpage>&#x02013;<lpage>667</lpage>.<pub-id pub-id-type="pmid">20478256</pub-id></mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><name><surname>Hamasaki</surname><given-names>M</given-names></name>, <name><surname>Furuta</surname><given-names>N</given-names></name>, <name><surname>Matsuda</surname><given-names>A</given-names></name>, <name><surname>Nezu</surname><given-names>A</given-names></name>, <name><surname>Yamamoto</surname><given-names>A</given-names></name>, <name><surname>Fujita</surname><given-names>N</given-names></name>, <name><surname>Oomori</surname><given-names>H</given-names></name>, <name><surname>Noda</surname><given-names>T</given-names></name>, <name><surname>Haraguchi</surname><given-names>T</given-names></name>, <name><surname>Hiraoka</surname><given-names>Y</given-names></name>, <etal/> (<year>2013</year>). <article-title>Autophagosomes form at
ER-mitochondria contact sites</article-title>. <source>Nature</source>
<volume>495</volume>,
<fpage>389</fpage>&#x02013;<lpage>393</lpage>.<pub-id pub-id-type="pmid">23455425</pub-id></mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name><surname>Hara</surname><given-names>T</given-names></name>, <name><surname>Nakamura</surname><given-names>K</given-names></name>, <name><surname>Matsui</surname><given-names>M</given-names></name>, <name><surname>Yamamoto</surname><given-names>A</given-names></name>, <name><surname>Nakahara</surname><given-names>Y</given-names></name>, <name><surname>Suzuki-Migishima</surname><given-names>R</given-names></name>, <name><surname>Yokoyama</surname><given-names>M</given-names></name>, <name><surname>Mishima</surname><given-names>K</given-names></name>, <name><surname>Saito</surname><given-names>I</given-names></name>, <name><surname>Okano</surname><given-names>H</given-names></name>, and <name><surname>Mizushima</surname><given-names>N</given-names></name> (<year>2006</year>). <article-title>Suppression of basal autophagy in
neural cells causes neurodegenerative disease in mice</article-title>.
<source>Nature</source>
<volume>441</volume>,
<fpage>885</fpage>&#x02013;<lpage>889</lpage>.<pub-id pub-id-type="pmid">16625204</pub-id></mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name><surname>Ichimura</surname><given-names>Y</given-names></name>, <name><surname>Kirisako</surname><given-names>T</given-names></name>, <name><surname>Takao</surname><given-names>T</given-names></name>, <name><surname>Satomi</surname><given-names>Y</given-names></name>, <name><surname>Shimonishi</surname><given-names>Y</given-names></name>, <name><surname>Ishihara</surname><given-names>N</given-names></name>, <name><surname>Mizushima</surname><given-names>N</given-names></name>, <name><surname>Tanida</surname><given-names>I</given-names></name>, <name><surname>Kominami</surname><given-names>E</given-names></name>, <name><surname>Ohsumi</surname><given-names>M</given-names></name>, <etal/> (<year>2000</year>). <article-title>A ubiquitin-like system
mediates protein lipidation</article-title>. <source>Nature</source>
<volume>408</volume>,
<fpage>488</fpage>&#x02013;<lpage>492</lpage>.<pub-id pub-id-type="pmid">11100732</pub-id></mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name><surname>Inoki</surname><given-names>K</given-names></name>, <name><surname>Zhu</surname><given-names>T</given-names></name>, and <name><surname>Guan</surname><given-names>KL</given-names></name> (<year>2003</year>). <article-title>TSC2 mediates cellular energy
response to control cell growth and survival</article-title>.
<source>Cell</source>
<volume>115</volume>,
<fpage>577</fpage>&#x02013;<lpage>590</lpage>.<pub-id pub-id-type="pmid">14651849</pub-id></mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name><surname>Jang</surname><given-names>SY</given-names></name>, <name><surname>Kang</surname><given-names>HT</given-names></name>, and <name><surname>Hwang</surname><given-names>ES</given-names></name> (<year>2012</year>). <article-title>Nicotinamide-induced mitophagy:
event mediated by high NAD+/NADH ratio and SIRT1 protein
activation</article-title>. <source>J. Biol. Chem</source>
<volume>287</volume>,
<fpage>19304</fpage>&#x02013;<lpage>19314</lpage>.<pub-id pub-id-type="pmid">22493485</pub-id></mixed-citation></ref><ref id="R30"><mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>SC</given-names></name>, <name><surname>Yanos</surname><given-names>ME</given-names></name>, <name><surname>Kayser</surname><given-names>EB</given-names></name>, <name><surname>Quintana</surname><given-names>A</given-names></name>, <name><surname>Sangesland</surname><given-names>M</given-names></name>, <name><surname>Castanza</surname><given-names>A</given-names></name>, <name><surname>Uhde</surname><given-names>L</given-names></name>, <name><surname>Hui</surname><given-names>J</given-names></name>, <name><surname>Wall</surname><given-names>VZ</given-names></name>, <name><surname>Gagnidze</surname><given-names>A</given-names></name>, <etal/> (<year>2013</year>). <article-title>mTOR inhibition alleviates
mitochondrial disease in a mouse model of Leigh syndrome</article-title>.
<source>Science</source>
<volume>342</volume>,
<fpage>1524</fpage>&#x02013;<lpage>1528</lpage>.<pub-id pub-id-type="pmid">24231806</pub-id></mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><name><surname>Kabeya</surname><given-names>Y</given-names></name>, <name><surname>Mizushima</surname><given-names>N</given-names></name>, <name><surname>Ueno</surname><given-names>T</given-names></name>, <name><surname>Yamamoto</surname><given-names>A</given-names></name>, <name><surname>Kirisako</surname><given-names>T</given-names></name>, <name><surname>Noda</surname><given-names>T</given-names></name>, <name><surname>Kominami</surname><given-names>E</given-names></name>, <name><surname>Ohsumi</surname><given-names>Y</given-names></name>, and <name><surname>Yoshimori</surname><given-names>T</given-names></name> (<year>2000</year>). <article-title>LC3, a mammalian homologue of yeast
Apg8p, is localized in autophagosome membranes after
processing</article-title>. <source>EMBO J</source>. <volume>19</volume>,
<fpage>5720</fpage>&#x02013;<lpage>5728</lpage>.<pub-id pub-id-type="pmid">11060023</pub-id></mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name><surname>Kabeya</surname><given-names>Y</given-names></name>, <name><surname>Mizushima</surname><given-names>N</given-names></name>, <name><surname>Yamamoto</surname><given-names>A</given-names></name>, <name><surname>Oshitani-Okamoto</surname><given-names>S</given-names></name>, <name><surname>Ohsumi</surname><given-names>Y</given-names></name>, and <name><surname>Yoshimori</surname><given-names>T</given-names></name> (<year>2004</year>). <article-title>LC3, GABARAP and GATE16 localize to
autophagosomal membrane depending on form-II formation</article-title>.
<source>J. Cell Sci</source>
<volume>117</volume>,
<fpage>2805</fpage>&#x02013;<lpage>2812</lpage>.<pub-id pub-id-type="pmid">15169837</pub-id></mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name><surname>Kalender</surname><given-names>A</given-names></name>, <name><surname>Selvaraj</surname><given-names>A</given-names></name>, <name><surname>Kim</surname><given-names>SY</given-names></name>, <name><surname>Gulati</surname><given-names>P</given-names></name>, <name><surname>Bru^l&#x000e9;</surname><given-names>S</given-names></name>, <name><surname>Viollet</surname><given-names>B</given-names></name>, <name><surname>Kemp</surname><given-names>BE</given-names></name>, <name><surname>Bardeesy</surname><given-names>N</given-names></name>, <name><surname>Dennis</surname><given-names>P</given-names></name>, <name><surname>Schlager</surname><given-names>JJ</given-names></name>, <etal/> (<year>2010</year>). <article-title>Metformin, independent of
AMPK, inhibits mTORC1 in a rag GTPase-dependent manner</article-title>.
<source>Cell Metab</source>. <volume>11</volume>,
<fpage>390</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="pmid">20444419</pub-id></mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><name><surname>Katayama</surname><given-names>H</given-names></name>, <name><surname>Kogure</surname><given-names>T</given-names></name>, <name><surname>Mizushima</surname><given-names>N</given-names></name>, <name><surname>Yoshimori</surname><given-names>T</given-names></name>, and <name><surname>Miyawaki</surname><given-names>A</given-names></name> (<year>2011</year>). <article-title>A sensitive and quantitative
technique for detecting autophagic events based on lysosomal
delivery</article-title>. <source>Chem. Biol</source>
<volume>18</volume>,
<fpage>1042</fpage>&#x02013;<lpage>1052</lpage>.<pub-id pub-id-type="pmid">21867919</pub-id></mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name><surname>Kaur</surname><given-names>J</given-names></name>, and <name><surname>Debnath</surname><given-names>J</given-names></name> (<year>2015</year>). <article-title>Autophagy at the crossroads of
catabolism and anabolism</article-title>. <source>Nat. Rev. Mol. Cell
Biol</source>
<volume>16</volume>,
<fpage>461</fpage>&#x02013;<lpage>472</lpage>.<pub-id pub-id-type="pmid">26177004</pub-id></mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Kundu</surname><given-names>M</given-names></name>, <name><surname>Viollet</surname><given-names>B</given-names></name>, and <name><surname>Guan</surname><given-names>KL</given-names></name> (<year>2011</year>). <article-title>AMPK and mTOR regulate autophagy
through direct phosphorylation of Ulk1</article-title>. <source>Nat. Cell
Biol</source>
<volume>13</volume>,
<fpage>132</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">21258367</pub-id></mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name><surname>Kimmelman</surname><given-names>AC</given-names></name>, and <name><surname>White</surname><given-names>E</given-names></name> (<year>2017</year>). <article-title>Autophagy and Tumor
Metabolism</article-title>. <source>Cell Metab</source>.
<volume>25</volume>,
<fpage>1037</fpage>&#x02013;<lpage>1043</lpage>.<pub-id pub-id-type="pmid">28467923</pub-id></mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Guo</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>S</given-names></name>, <name><surname>Huang</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>N</given-names></name>, <name><surname>Yang</surname><given-names>C</given-names></name>, <name><surname>Tang</surname><given-names>P</given-names></name>, and <name><surname>Liu</surname><given-names>J</given-names></name> (<year>2013</year>). <article-title>Intracellular ATP concentration
contributes to the cytotoxic and cytoprotective effects of
adenosine</article-title>. <source>PLoS ONE</source>
<volume>8</volume>, <fpage>e76731</fpage>.<pub-id pub-id-type="pmid">24098558</pub-id></mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>TY</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>Q</given-names></name>, <name><surname>Shi</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>CS</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Song</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <etal/> (<year>2016</year>). <article-title>ULK1/2 Constitute a
Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to
Autophagy</article-title>. <source>Mol. Cell</source>
<volume>62</volume>,
<fpage>359</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">27153534</pub-id></mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><name><surname>Locasale</surname><given-names>JW</given-names></name> (<year>2013</year>). <article-title>Serine, glycine and one-carbon
units: cancer metabolism in full circle</article-title>. <source>Nat. Rev.
Cancer</source>
<volume>13</volume>,
<fpage>572</fpage>&#x02013;<lpage>583</lpage>.<pub-id pub-id-type="pmid">23822983</pub-id></mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name><surname>Lockwood</surname><given-names>TD</given-names></name> (<year>2010</year>). <article-title>The lysosome among targets of
metformin: new antiinflammatory uses for an old drug?</article-title>
<source>Expert Opin. Ther. Targets</source>
<volume>14</volume>,
<fpage>467</fpage>&#x02013;<lpage>478</lpage>.<pub-id pub-id-type="pmid">20392164</pub-id></mixed-citation></ref><ref id="R42"><mixed-citation publication-type="journal"><name><surname>Lorin</surname><given-names>S</given-names></name>, <name><surname>Hama&#x000ef;</surname><given-names>A</given-names></name>, <name><surname>Mehrpour</surname><given-names>M</given-names></name>, and <name><surname>Codogno</surname><given-names>P</given-names></name> (<year>2013</year>). <article-title>Autophagy regulation and its role in
cancer</article-title>. <source>Semin. Cancer Biol</source>
<volume>23</volume>,
<fpage>361</fpage>&#x02013;<lpage>379</lpage>.<pub-id pub-id-type="pmid">23811268</pub-id></mixed-citation></ref><ref id="R43"><mixed-citation publication-type="journal"><name><surname>Madiraju</surname><given-names>AK</given-names></name>, <name><surname>Erion</surname><given-names>DM</given-names></name>, <name><surname>Rahimi</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>XM</given-names></name>, <name><surname>Braddock</surname><given-names>DT</given-names></name>, <name><surname>Albright</surname><given-names>RA</given-names></name>, <name><surname>Prigaro</surname><given-names>BJ</given-names></name>, <name><surname>Wood</surname><given-names>JL</given-names></name>, <name><surname>Bhanot</surname><given-names>S</given-names></name>, <name><surname>MacDonald</surname><given-names>MJ</given-names></name>, <etal/> (<year>2014</year>). <article-title>Metformin suppresses
gluconeogenesis by inhibiting mitochondrial glycerophosphate
dehydrogenase</article-title>. <source>Nature</source>
<volume>510</volume>,
<fpage>542</fpage>&#x02013;<lpage>546</lpage>.<pub-id pub-id-type="pmid">24847880</pub-id></mixed-citation></ref><ref id="R44"><mixed-citation publication-type="journal"><name><surname>Marroquin</surname><given-names>LD</given-names></name>, <name><surname>Hynes</surname><given-names>J</given-names></name>, <name><surname>Dykens</surname><given-names>JA</given-names></name>, <name><surname>Jamieson</surname><given-names>JD</given-names></name>, and <name><surname>Will</surname><given-names>Y</given-names></name> (<year>2007</year>). <article-title>Circumventing the Crabtree effect:
replacing media glucose with galactose increases susceptibility of HepG2
cells to mitochondrial toxicants</article-title>. <source>Toxicol.
Sci</source>
<volume>97</volume>,
<fpage>539</fpage>&#x02013;<lpage>547</lpage>.<pub-id pub-id-type="pmid">17361016</pub-id></mixed-citation></ref><ref id="R45"><mixed-citation publication-type="journal"><name><surname>Meijer</surname><given-names>AJ</given-names></name>, and <name><surname>Codogno</surname><given-names>P</given-names></name> (<year>2011</year>). <article-title>Autophagy: regulation by energy
sensing</article-title>. <source>Curr. Biol</source>
<volume>21</volume>,
<fpage>R227</fpage>&#x02013;<lpage>R229</lpage>.<pub-id pub-id-type="pmid">21419990</pub-id></mixed-citation></ref><ref id="R46"><mixed-citation publication-type="journal"><name><surname>Meley</surname><given-names>D</given-names></name>, <name><surname>Bauvy</surname><given-names>C</given-names></name>, <name><surname>Houben-Weerts</surname><given-names>JH</given-names></name>, <name><surname>Dubbelhuis</surname><given-names>PF</given-names></name>, <name><surname>Helmond</surname><given-names>MT</given-names></name>, <name><surname>Codogno</surname><given-names>P</given-names></name>, and <name><surname>Meijer</surname><given-names>AJ</given-names></name> (<year>2006</year>). <article-title>AMP-activated protein kinase and the
regulation of autophagic proteolysis</article-title>. <source>J. Biol.
Chem</source>
<volume>281</volume>,
<fpage>34870</fpage>&#x02013;<lpage>34879</lpage>.<pub-id pub-id-type="pmid">16990266</pub-id></mixed-citation></ref><ref id="R47"><mixed-citation publication-type="journal"><name><surname>Melser</surname><given-names>S</given-names></name>, <name><surname>Chatelain</surname><given-names>EH</given-names></name>, <name><surname>Lavie</surname><given-names>J</given-names></name>, <name><surname>Mahfouf</surname><given-names>W</given-names></name>, <name><surname>Jose</surname><given-names>C</given-names></name>, <name><surname>Obre</surname><given-names>E</given-names></name>, <name><surname>Goorden</surname><given-names>S</given-names></name>, <name><surname>Priault</surname><given-names>M</given-names></name>, <name><surname>Elgersma</surname><given-names>Y</given-names></name>, <name><surname>Rezvani</surname><given-names>HR</given-names></name>, <etal/> (<year>2013</year>). <article-title>Rheb regulates mitophagy
induced by mitochondrial energetic status</article-title>. <source>Cell
Metab</source>. <volume>17</volume>,
<fpage>719</fpage>&#x02013;<lpage>730</lpage>.<pub-id pub-id-type="pmid">23602449</pub-id></mixed-citation></ref><ref id="R48"><mixed-citation publication-type="journal"><name><surname>Menzies</surname><given-names>FM</given-names></name>, <name><surname>Fleming</surname><given-names>A</given-names></name>, <name><surname>Caricasole</surname><given-names>A</given-names></name>, <name><surname>Bento</surname><given-names>CF</given-names></name>, <name><surname>Andrews</surname><given-names>SP</given-names></name>, <name><surname>Ashkenazi</surname><given-names>A</given-names></name>, <name><surname>F&#x000fc;llgrabe</surname><given-names>J</given-names></name>, <name><surname>Jackson</surname><given-names>A</given-names></name>, <name><surname>Jimenez Sanchez</surname><given-names>M</given-names></name>, <name><surname>Karabiyik</surname><given-names>C</given-names></name>, <etal/> (<year>2017</year>). <article-title>Autophagy and
Neurodegeneration: Pathogenic Mechanisms and Therapeutic
Opportunities</article-title>. <source>Neuron</source>
<volume>93</volume>,
<fpage>1015</fpage>&#x02013;<lpage>1034</lpage>.<pub-id pub-id-type="pmid">28279350</pub-id></mixed-citation></ref><ref id="R49"><mixed-citation publication-type="journal"><name><surname>Mercer</surname><given-names>CA</given-names></name>, <name><surname>Kaliappan</surname><given-names>A</given-names></name>, and <name><surname>Dennis</surname><given-names>PB</given-names></name> (<year>2008</year>). <article-title>Macroautophagy-dependent,
intralysosomal cleavage of a betaine homocysteine methyltransferase fusion
protein requires stable multimerization</article-title>.
<source>Autophagy</source>
<volume>4</volume>,
<fpage>185</fpage>&#x02013;<lpage>194</lpage>.<pub-id pub-id-type="pmid">18059170</pub-id></mixed-citation></ref><ref id="R50"><mixed-citation publication-type="journal"><name><surname>Mercer</surname><given-names>CA</given-names></name>, <name><surname>Kaliappan</surname><given-names>A</given-names></name>, and <name><surname>Dennis</surname><given-names>PB</given-names></name> (<year>2009</year>). <article-title>A novel, human Atg13 binding
protein, Atg101, interacts with ULK1 and is essential for
macroautophagy</article-title>. <source>Autophagy</source>
<volume>5</volume>,
<fpage>649</fpage>&#x02013;<lpage>662</lpage>.<pub-id pub-id-type="pmid">19287211</pub-id></mixed-citation></ref><ref id="R51"><mixed-citation publication-type="journal"><name><surname>Miyata</surname><given-names>N</given-names></name>, <name><surname>Watanabe</surname><given-names>Y</given-names></name>, <name><surname>Tamura</surname><given-names>Y</given-names></name>, <name><surname>Endo</surname><given-names>T</given-names></name>, and <name><surname>Kuge</surname><given-names>O</given-names></name> (<year>2016</year>). <article-title>Phosphatidylserine transport by
Ups2-Mdm35 in respiration-active mitochondria</article-title>. <source>J.
Cell Biol</source>
<volume>214</volume>,
<fpage>77</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">27354379</pub-id></mixed-citation></ref><ref id="R52"><mixed-citation publication-type="journal"><name><surname>Morita</surname><given-names>M</given-names></name>, <name><surname>Gravel</surname><given-names>SP</given-names></name>, <name><surname>Ch&#x000e9;nard</surname><given-names>V</given-names></name>, <name><surname>Sikstr&#x000f6;m</surname><given-names>K</given-names></name>, <name><surname>Zheng</surname><given-names>L</given-names></name>, <name><surname>Alain</surname><given-names>T</given-names></name>, <name><surname>Gandin</surname><given-names>V</given-names></name>, <name><surname>Avizonis</surname><given-names>D</given-names></name>, <name><surname>Arguello</surname><given-names>M</given-names></name>, <name><surname>Zakaria</surname><given-names>C</given-names></name>, <etal/> (<year>2013</year>). <article-title>mTORC1 controls
mitochondrial activity and biogenesis through 4E-BP-dependent translational
regulation</article-title>. <source>Cell Metab</source>.
<volume>18</volume>,
<fpage>698</fpage>&#x02013;<lpage>711</lpage>.<pub-id pub-id-type="pmid">24206664</pub-id></mixed-citation></ref><ref id="R53"><mixed-citation publication-type="journal"><name><surname>Naon</surname><given-names>D</given-names></name>, and <name><surname>Scorrano</surname><given-names>L</given-names></name> (<year>2014</year>). <article-title>At the right distance:
ER-mitochondria juxtaposition in cell life and death</article-title>.
<source>Biochim. Biophys. Acta</source>
<volume>1843</volume>,
<fpage>2184</fpage>&#x02013;<lpage>2194</lpage>.<pub-id pub-id-type="pmid">24875902</pub-id></mixed-citation></ref><ref id="R54"><mixed-citation publication-type="journal"><name><surname>Narendra</surname><given-names>DP</given-names></name>, <name><surname>Jin</surname><given-names>SM</given-names></name>, <name><surname>Tanaka</surname><given-names>A</given-names></name>, <name><surname>Suen</surname><given-names>DF</given-names></name>, <name><surname>Gautier</surname><given-names>CA</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name>, <name><surname>Cookson</surname><given-names>MR</given-names></name>, and <name><surname>Youle</surname><given-names>RJ</given-names></name> (<year>2010</year>). <article-title>PINK1 is selectively stabilized on
impaired mitochondria to activate Parkin</article-title>. <source>PLoS
Biol</source>. <volume>8</volume>, <fpage>e1000298</fpage>.<pub-id pub-id-type="pmid">20126261</pub-id></mixed-citation></ref><ref id="R55"><mixed-citation publication-type="journal"><name><surname>Noda</surname><given-names>T</given-names></name> (<year>2017</year>). <article-title>Regulation of Autophagy through
TORC1 and mTORC1</article-title>. <source>Biomolecules</source>
<volume>7</volume>, <fpage>E52</fpage>.<pub-id pub-id-type="pmid">28686223</pub-id></mixed-citation></ref><ref id="R56"><mixed-citation publication-type="journal"><name><surname>Owen</surname><given-names>MR</given-names></name>, <name><surname>Doran</surname><given-names>E</given-names></name>, and <name><surname>Halestrap</surname><given-names>AP</given-names></name> (<year>2000</year>). <article-title>Evidence that metformin exerts its
anti-diabetic effects through inhibition of complex 1 of the mitochondrial
respiratory chain</article-title>. <source>Biochem. J</source>
<volume>348</volume>,
<fpage>607</fpage>&#x02013;<lpage>614</lpage>.<pub-id pub-id-type="pmid">10839993</pub-id></mixed-citation></ref><ref id="R57"><mixed-citation publication-type="journal"><name><surname>Palmer</surname><given-names>G</given-names></name>, <name><surname>Horgan</surname><given-names>DJ</given-names></name>, <name><surname>Tisdale</surname><given-names>H</given-names></name>, <name><surname>Singer</surname><given-names>TP</given-names></name>, and <name><surname>Beinert</surname><given-names>H</given-names></name> (<year>1968</year>). <article-title>Studies on the respiratory
chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XIV.
Location of the sites of inhibition of rotenone, barbiturates, and
piericidin by means of electron paramagnetic resonance
spectroscopy</article-title>. <source>J. Biol. Chem</source>
<volume>243</volume>,
<fpage>844</fpage>&#x02013;<lpage>847</lpage>.<pub-id pub-id-type="pmid">4295607</pub-id></mixed-citation></ref><ref id="R58"><mixed-citation publication-type="journal"><name><surname>Pankiv</surname><given-names>S</given-names></name>, <name><surname>Clausen</surname><given-names>TH</given-names></name>, <name><surname>Lamark</surname><given-names>T</given-names></name>, <name><surname>Brech</surname><given-names>A</given-names></name>, <name><surname>Bruun</surname><given-names>JA</given-names></name>, <name><surname>Outzen</surname><given-names>H</given-names></name>, <name><surname>&#x000d8;ver-vatn</surname><given-names>A</given-names></name>, <name><surname>Bj&#x000f8;rk&#x000f8;y</surname><given-names>G</given-names></name>, and <name><surname>Johansen</surname><given-names>T</given-names></name> (<year>2007</year>). <article-title>p62/SQSTM1 binds directly to
Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by
autophagy</article-title>. <source>J. Biol. Chem</source>
<volume>282</volume>,
<fpage>24131</fpage>&#x02013;<lpage>24145</lpage>.<pub-id pub-id-type="pmid">17580304</pub-id></mixed-citation></ref><ref id="R59"><mixed-citation publication-type="journal"><name><surname>Pickles</surname><given-names>S</given-names></name>, <name><surname>Vigi&#x000e9;</surname><given-names>P</given-names></name>, and <name><surname>Youle</surname><given-names>RJ</given-names></name> (<year>2018</year>). <article-title>Mitophagy and Quality Control
Mechanisms in Mitochondrial Maintenance</article-title>. <source>Curr.
Biol</source>
<volume>28</volume>,
<fpage>R170</fpage>&#x02013;<lpage>R185</lpage>.<pub-id pub-id-type="pmid">29462587</pub-id></mixed-citation></ref><ref id="R60"><mixed-citation publication-type="journal"><name><surname>Pickrell</surname><given-names>AM</given-names></name>, and <name><surname>Youle</surname><given-names>RJ</given-names></name> (<year>2015</year>). <article-title>The roles of PINK1, parkin, and
mitochondrial fidelity in Parkinson&#x02019;s disease</article-title>.
<source>Neuron</source>
<volume>85</volume>,
<fpage>257</fpage>&#x02013;<lpage>273</lpage>.<pub-id pub-id-type="pmid">25611507</pub-id></mixed-citation></ref><ref id="R61"><mixed-citation publication-type="journal"><name><surname>Pietrocola</surname><given-names>F</given-names></name>, <name><surname>Izzo</surname><given-names>V</given-names></name>, <name><surname>Niso-Santano</surname><given-names>M</given-names></name>, <name><surname>Vacchelli</surname><given-names>E</given-names></name>, <name><surname>Galluzzi</surname><given-names>L</given-names></name>, <name><surname>Maiuri</surname><given-names>MC</given-names></name>, and <name><surname>Kroemer</surname><given-names>G</given-names></name> (<year>2013</year>). <article-title>Regulation of autophagy by
stress-responsive transcription factors</article-title>. <source>Semin.
Cancer Biol</source>
<volume>23</volume>,
<fpage>310</fpage>&#x02013;<lpage>322</lpage>.<pub-id pub-id-type="pmid">23726895</pub-id></mixed-citation></ref><ref id="R62"><mixed-citation publication-type="journal"><name><surname>Plomp</surname><given-names>PJ</given-names></name>, <name><surname>Gordon</surname><given-names>PB</given-names></name>, <name><surname>Meijer</surname><given-names>AJ</given-names></name>, <name><surname>H&#x000f8;yvik</surname><given-names>H</given-names></name>, and <name><surname>Seglen</surname><given-names>PO</given-names></name> (<year>1989</year>). <article-title>Energy dependence of different steps
in the autophagic-lysosomal pathway</article-title>. <source>J. Biol.
Chem</source>
<volume>264</volume>,
<fpage>6699</fpage>&#x02013;<lpage>6704</lpage>.<pub-id pub-id-type="pmid">2708336</pub-id></mixed-citation></ref><ref id="R63"><mixed-citation publication-type="journal"><name><surname>Polson</surname><given-names>HE</given-names></name>, <name><surname>de Lartigue</surname><given-names>J</given-names></name>, <name><surname>Rigden</surname><given-names>DJ</given-names></name>, <name><surname>Reedijk</surname><given-names>M</given-names></name>, <name><surname>Urb&#x000e9;</surname><given-names>S</given-names></name>, <name><surname>Clague</surname><given-names>MJ</given-names></name>, and <name><surname>Tooze</surname><given-names>SA</given-names></name> (<year>2010</year>). <article-title>Mammalian Atg18 (WIPI2) localizes to
omegasomeanchored phagophores and positively regulates LC3
lipidation</article-title>. <source>Autophagy</source>
<volume>6</volume>,
<fpage>506</fpage>&#x02013;<lpage>522</lpage>.<pub-id pub-id-type="pmid">20505359</pub-id></mixed-citation></ref><ref id="R64"><mixed-citation publication-type="journal"><name><surname>Prabhu</surname><given-names>V</given-names></name>, <name><surname>Srivastava</surname><given-names>P</given-names></name>, <name><surname>Yadav</surname><given-names>N</given-names></name>, <name><surname>Amadori</surname><given-names>M</given-names></name>, <name><surname>Schneider</surname><given-names>A</given-names></name>, <name><surname>Seshadri</surname><given-names>A</given-names></name>, <name><surname>Pitarresi</surname><given-names>J</given-names></name>, <name><surname>Scott</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Koochekpour</surname><given-names>S</given-names></name>, <etal/> (<year>2013</year>). <article-title>Resveratrol depletes
mitochondrial DNA and inhibition of autophagy enhances resveratrol-induced
caspase activation</article-title>. <source>Mitochondrion</source>
<volume>13</volume>,
<fpage>493</fpage>&#x02013;<lpage>499</lpage>.<pub-id pub-id-type="pmid">23088850</pub-id></mixed-citation></ref><ref id="R65"><mixed-citation publication-type="journal"><name><surname>Ramirez-Peinado</surname><given-names>S</given-names></name>, <name><surname>Leon-Annicchiarico</surname><given-names>CL</given-names></name>, <name><surname>Galindo-Moreno</surname><given-names>J</given-names></name>, <name><surname>Iurlaro</surname><given-names>R</given-names></name>, <name><surname>Caro-Maldonado</surname><given-names>A</given-names></name>, <name><surname>Prehn</surname><given-names>JH</given-names></name>, <name><surname>Ryan</surname><given-names>KM</given-names></name>, and <name><surname>Munoz-Pinedo</surname><given-names>C</given-names></name> (<year>2013</year>). <article-title>Glucose-starved cells do not engage
in prosurvival autophagy</article-title>. <source>J. Biol. Chem</source>
<volume>288</volume>,
<fpage>30387</fpage>&#x02013;<lpage>30398</lpage>.<pub-id pub-id-type="pmid">24014036</pub-id></mixed-citation></ref><ref id="R66"><mixed-citation publication-type="journal"><name><surname>Rockenfeller</surname><given-names>P</given-names></name>, <name><surname>Koska</surname><given-names>M</given-names></name>, <name><surname>Pietrocola</surname><given-names>F</given-names></name>, <name><surname>Minois</surname><given-names>N</given-names></name>, <name><surname>Knittelfelder</surname><given-names>O</given-names></name>, <name><surname>Sica</surname><given-names>V</given-names></name>, <name><surname>Franz</surname><given-names>J</given-names></name>, <name><surname>Carmona-Gutierrez</surname><given-names>D</given-names></name>, <name><surname>Kroemer</surname><given-names>G</given-names></name>, and <name><surname>Madeo</surname><given-names>F</given-names></name> (<year>2015</year>). <article-title>Phosphatidylethanolamine positively
regulates autophagy and longevity</article-title>. <source>Cell Death
Differ</source>. <volume>22</volume>,
<fpage>499</fpage>&#x02013;<lpage>508</lpage>.<pub-id pub-id-type="pmid">25571976</pub-id></mixed-citation></ref><ref id="R67"><mixed-citation publication-type="journal"><name><surname>Rodenburg</surname><given-names>RJ</given-names></name> (<year>2016</year>). <article-title>Mitochondrial complex I-linked
disease</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1857</volume>,
<fpage>938</fpage>&#x02013;<lpage>945</lpage>.<pub-id pub-id-type="pmid">26906428</pub-id></mixed-citation></ref><ref id="R68"><mixed-citation publication-type="journal"><name><surname>Roser</surname><given-names>M</given-names></name>, <name><surname>Josic</surname><given-names>D</given-names></name>, <name><surname>Kontou</surname><given-names>M</given-names></name>, <name><surname>Mosetter</surname><given-names>K</given-names></name>, <name><surname>Maurer</surname><given-names>P</given-names></name>, and <name><surname>Reutter</surname><given-names>W</given-names></name> (<year>2009</year>). <article-title>Metabolism of galactose in the brain
and liver of rats and its conversion into glutamate and other amino
acids</article-title>. <source>J. Neural Transm. (Vienna)</source>
<volume>116</volume>,
<fpage>131</fpage>&#x02013;<lpage>139</lpage>.<pub-id pub-id-type="pmid">19089315</pub-id></mixed-citation></ref><ref id="R69"><mixed-citation publication-type="journal"><name><surname>Russell</surname><given-names>RC</given-names></name>, <name><surname>Yuan</surname><given-names>HX</given-names></name>, and <name><surname>Guan</surname><given-names>KL</given-names></name> (<year>2014</year>). <article-title>Autophagy regulation by nutrient
signaling</article-title>. <source>Cell Res</source>. <volume>24</volume>,
<fpage>42</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">24343578</pub-id></mixed-citation></ref><ref id="R70"><mixed-citation publication-type="journal"><name><surname>Samari</surname><given-names>HR</given-names></name>, and <name><surname>Seglen</surname><given-names>PO</given-names></name> (<year>1998</year>). <article-title>Inhibition of hepatocytic autophagy
by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine
riboside. Evidence for involvement of amp-activated protein
kinase</article-title>. <source>J. Biol. Chem</source>
<volume>273</volume>,
<fpage>23758</fpage>&#x02013;<lpage>23763</lpage>.<pub-id pub-id-type="pmid">9726984</pub-id></mixed-citation></ref><ref id="R71"><mixed-citation publication-type="journal"><name><surname>Sancak</surname><given-names>Y</given-names></name>, <name><surname>Bar-Peled</surname><given-names>L</given-names></name>, <name><surname>Zoncu</surname><given-names>R</given-names></name>, <name><surname>Markhard</surname><given-names>AL</given-names></name>, <name><surname>Nada</surname><given-names>S</given-names></name>, and <name><surname>Sabatini</surname><given-names>DM</given-names></name> (<year>2010</year>). <article-title>Ragulator-Rag complex targets mTORC1
to the lysosomal surface and is necessary for its activation by amino
acids</article-title>. <source>Cell</source>
<volume>141</volume>,
<fpage>290</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="pmid">20381137</pub-id></mixed-citation></ref><ref id="R72"><mixed-citation publication-type="journal"><name><surname>Sarkar</surname><given-names>S</given-names></name>, <name><surname>Davies</surname><given-names>JE</given-names></name>, <name><surname>Huang</surname><given-names>Z</given-names></name>, <name><surname>Tunnacliffe</surname><given-names>A</given-names></name>, and <name><surname>Rubinsztein</surname><given-names>DC</given-names></name> (<year>2007</year>). <article-title>Trehalose, a novel mTOR-independent
autophagy enhancer, accelerates the clearance of mutant huntingtin and
alpha-synuclein</article-title>. <source>J. Biol. Chem</source>
<volume>282</volume>,
<fpage>5641</fpage>&#x02013;<lpage>5652</lpage>.<pub-id pub-id-type="pmid">17182613</pub-id></mixed-citation></ref><ref id="R73"><mixed-citation publication-type="journal"><name><surname>Schellens</surname><given-names>JP</given-names></name>, and <name><surname>Meijer</surname><given-names>AJ</given-names></name> (<year>1991</year>). <article-title>Energy depletion and autophagy.
Cytochemical and biochemical studies in isolated rat
hepatocytes</article-title>. <source>Histochem. J</source>
<volume>23</volume>,
<fpage>460</fpage>&#x02013;<lpage>466</lpage>.<pub-id pub-id-type="pmid">1743994</pub-id></mixed-citation></ref><ref id="R74"><mixed-citation publication-type="journal"><name><surname>Shackelford</surname><given-names>DB</given-names></name>, <name><surname>Abt</surname><given-names>E</given-names></name>, <name><surname>Gerken</surname><given-names>L</given-names></name>, <name><surname>Vasquez</surname><given-names>DS</given-names></name>, <name><surname>Seki</surname><given-names>A</given-names></name>, <name><surname>Leblanc</surname><given-names>M</given-names></name>, <name><surname>Wei</surname><given-names>L</given-names></name>, <name><surname>Fishbein</surname><given-names>MC</given-names></name>, <name><surname>Czernin</surname><given-names>J</given-names></name>, <name><surname>Mischel</surname><given-names>PS</given-names></name>, and <name><surname>Shaw</surname><given-names>RJ</given-names></name> (<year>2013</year>). <article-title>LKB1 inactivation dictates
therapeutic response of non-small cell lung cancer to the metabolism drug
phenformin</article-title>. <source>Cancer Cell</source>
<volume>23</volume>,
<fpage>143</fpage>&#x02013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">23352126</pub-id></mixed-citation></ref><ref id="R75"><mixed-citation publication-type="journal"><name><surname>Shiao</surname><given-names>YJ</given-names></name>, <name><surname>Lupo</surname><given-names>G</given-names></name>, and <name><surname>Vance</surname><given-names>JE</given-names></name> (<year>1995</year>). <article-title>Evidence that phosphatidylserine is
imported into mitochondria via a mitochondria-associated membrane and that
the majority of mitochondrial phosphatidylethanolamine is derived from
decarboxylation of phosphatidylserine</article-title>. <source>J. Biol.
Chem</source>
<volume>270</volume>,
<fpage>11190</fpage>&#x02013;<lpage>11198</lpage>.<pub-id pub-id-type="pmid">7744750</pub-id></mixed-citation></ref><ref id="R76"><mixed-citation publication-type="journal"><name><surname>Shin</surname><given-names>HJ</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Oh</surname><given-names>S</given-names></name>, <name><surname>Lee</surname><given-names>JG</given-names></name>, <name><surname>Kee</surname><given-names>M</given-names></name>, <name><surname>Ko</surname><given-names>HJ</given-names></name>, <name><surname>Kweon</surname><given-names>MN</given-names></name>, <name><surname>Won</surname><given-names>KJ</given-names></name>, and <name><surname>Baek</surname><given-names>SH</given-names></name> (<year>2016</year>). <article-title>AMPK-SKP2-CARM1 signalling cascade
in transcriptional regulation of autophagy</article-title>.
<source>Nature</source>
<volume>534</volume>,
<fpage>553</fpage>&#x02013;<lpage>557</lpage>.<pub-id pub-id-type="pmid">27309807</pub-id></mixed-citation></ref><ref id="R77"><mixed-citation publication-type="journal"><name><surname>Stroud</surname><given-names>DA</given-names></name>, <name><surname>Surgenor</surname><given-names>EE</given-names></name>, <name><surname>Formosa</surname><given-names>LE</given-names></name>, <name><surname>Reljic</surname><given-names>B</given-names></name>, <name><surname>Frazier</surname><given-names>AE</given-names></name>, <name><surname>Dibley</surname><given-names>MG</given-names></name>, <name><surname>Osellame</surname><given-names>LD</given-names></name>, <name><surname>Stait</surname><given-names>T</given-names></name>, <name><surname>Beilharz</surname><given-names>TH</given-names></name>, <name><surname>Thorburn</surname><given-names>DR</given-names></name>, <etal/> (<year>2016</year>). <article-title>Accessory subunits are
integral for assembly and function of human mitochondrial complex
I</article-title>. <source>Nature</source>
<volume>538</volume>,
<fpage>123</fpage>&#x02013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">27626371</pub-id></mixed-citation></ref><ref id="R78"><mixed-citation publication-type="journal"><name><surname>Sullivan</surname><given-names>LB</given-names></name>, <name><surname>Gui</surname><given-names>DY</given-names></name>, <name><surname>Hosios</surname><given-names>AM</given-names></name>, <name><surname>Bush</surname><given-names>LN</given-names></name>, <name><surname>Freinkman</surname><given-names>E</given-names></name>, and <name><surname>Vander Heiden</surname><given-names>MG</given-names></name> (<year>2015</year>). <article-title>Supporting Aspartate Biosynthesis Is
an Essential Function of Respiration in Proliferating Cells</article-title>.
<source>Cell</source>
<volume>162</volume>,
<fpage>552</fpage>&#x02013;<lpage>563</lpage>.<pub-id pub-id-type="pmid">26232225</pub-id></mixed-citation></ref><ref id="R79"><mixed-citation publication-type="journal"><name><surname>Theurey</surname><given-names>P</given-names></name>, <name><surname>Tubbs</surname><given-names>E</given-names></name>, <name><surname>Vial</surname><given-names>G</given-names></name>, <name><surname>Jacquemetton</surname><given-names>J</given-names></name>, <name><surname>Bendridi</surname><given-names>N</given-names></name>, <name><surname>Chauvin</surname><given-names>MA</given-names></name>, <name><surname>Alam</surname><given-names>MR</given-names></name>, <name><surname>Le Romancer</surname><given-names>M</given-names></name>, <name><surname>Vidal</surname><given-names>H</given-names></name>, and <name><surname>Rieusset</surname><given-names>J</given-names></name> (<year>2016</year>). <article-title>Mitochondriaassociated endoplasmic
reticulum membranes allow adaptation of mitochondrial metabolism to glucose
availability in the liver</article-title>. <source>J. Mol. Cell
Biol</source>
<volume>8</volume>,
<fpage>129</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="pmid">26892023</pub-id></mixed-citation></ref><ref id="R80"><mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>HE</given-names></name>, <name><surname>Mercer</surname><given-names>CA</given-names></name>, <name><surname>Carnevalli</surname><given-names>LS</given-names></name>, <name><surname>Park</surname><given-names>J</given-names></name>, <name><surname>Andersen</surname><given-names>JB</given-names></name>, <name><surname>Conner</surname><given-names>EA</given-names></name>, <name><surname>Tanaka</surname><given-names>K</given-names></name>, <name><surname>Matsutani</surname><given-names>T</given-names></name>, <name><surname>Iwanami</surname><given-names>A</given-names></name>, <name><surname>Aronow</surname><given-names>BJ</given-names></name>, <etal/> (<year>2012</year>). <article-title>mTOR inhibitors synergize
on regression, reversal of gene expression, and autophagy in hepatocellular
carcinoma</article-title>. <source>Sci. Transl. Med</source>
<volume>4</volume>, <fpage>139</fpage>ra<lpage>84</lpage>.</mixed-citation></ref><ref id="R81"><mixed-citation publication-type="journal"><name><surname>Toyama</surname><given-names>EQ</given-names></name>, <name><surname>Herzig</surname><given-names>S</given-names></name>, <name><surname>Courchet</surname><given-names>J</given-names></name>, <name><surname>Lewis</surname><given-names>TL</given-names><suffix>Jr.</suffix></name>, <name><surname>Los&#x000f3;n</surname><given-names>OC</given-names></name>, <name><surname>Hellberg</surname><given-names>K</given-names></name>, <name><surname>Young</surname><given-names>NP</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Polleux</surname><given-names>F</given-names></name>, <name><surname>Chan</surname><given-names>DC</given-names></name>, and <name><surname>Shaw</surname><given-names>RJ</given-names></name> (<year>2016</year>). <article-title>Metabolism. AMP-activated protein
kinase mediates mitochondrial fission in response to energy
stress</article-title>. <source>Science</source>
<volume>351</volume>,
<fpage>275</fpage>&#x02013;<lpage>281</lpage>.<pub-id pub-id-type="pmid">26816379</pub-id></mixed-citation></ref><ref id="R82"><mixed-citation publication-type="journal"><name><surname>Tubbs</surname><given-names>E</given-names></name>, and <name><surname>Rieusset</surname><given-names>J</given-names></name> (<year>2016</year>). <source>S</source><article-title>tudy of
Endoplasmic Reticulum and Mitochondria Interactions by In Situ Proximity
Ligation Assay in Fixed Cells</article-title>. <source>J. Vis.
Exp</source>, <volume>118</volume>, <fpage>e54899</fpage>.</mixed-citation></ref><ref id="R83"><mixed-citation publication-type="journal"><name><surname>Vance</surname><given-names>JE</given-names></name>, and <name><surname>Tasseva</surname><given-names>G</given-names></name> (<year>2013</year>). <article-title>Formation and function of
phosphatidylserine and phosphatidylethanolamine in mammalian
cells</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1831</volume>,
<fpage>543</fpage>&#x02013;<lpage>554</lpage>.<pub-id pub-id-type="pmid">22960354</pub-id></mixed-citation></ref><ref id="R84"><mixed-citation publication-type="journal"><name><surname>Veiga</surname><given-names>SR</given-names></name>, <name><surname>Ge</surname><given-names>X</given-names></name>, <name><surname>Mercer</surname><given-names>CA</given-names></name>, <name><surname>Hern&#x000e1; ndez-&#x000c1; lvarez</surname><given-names>MI</given-names></name>, <name><surname>Thomas</surname><given-names>HE</given-names></name>, <name><surname>Hernandez-Losa</surname><given-names>J</given-names></name>, <name><surname>Ram&#x000f3; n Y Cajal</surname><given-names>S</given-names></name>, <name><surname>Zorzano</surname><given-names>A</given-names></name>, <name><surname>Thomas</surname><given-names>G</given-names></name>, and <name><surname>Kozma</surname><given-names>SC</given-names></name>(<year>2018</year>). <article-title>Phenformin-Induced Mitochondrial
Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of
mTOR</article-title>. <source>Clin. Cancer Res</source>.
<volume>24</volume>,
<fpage>3767</fpage>&#x02013;<lpage>3780</lpage>.<pub-id pub-id-type="pmid">29691292</pub-id></mixed-citation></ref><ref id="R85"><mixed-citation publication-type="journal"><name><surname>Venegas</surname><given-names>V</given-names></name>, and <name><surname>Halberg</surname><given-names>MC</given-names></name> (<year>2012</year>). <article-title>Measurement of mitochondrial DNA
copy number</article-title>. <source>Methods Mol. Biol</source>.
<volume>837</volume>,
<fpage>327</fpage>&#x02013;<lpage>335</lpage>.<pub-id pub-id-type="pmid">22215558</pub-id></mixed-citation></ref><ref id="R86"><mixed-citation publication-type="journal"><name><surname>Voelker</surname><given-names>DR</given-names></name> (<year>1993</year>). <article-title>The ATP-dependent translocation of
phosphatidylserine to the mitochondria is a process that is restricted to
the autologous organelle</article-title>. <source>J. Biol. Chem</source>
<volume>268</volume>,
<fpage>7069</fpage>&#x02013;<lpage>7074</lpage>.<pub-id pub-id-type="pmid">8463240</pub-id></mixed-citation></ref><ref id="R87"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Wilson</surname><given-names>WA</given-names></name>, <name><surname>Fujino</surname><given-names>MA</given-names></name>, and <name><surname>Roach</surname><given-names>PJ</given-names></name> (<year>2001</year>). <article-title>Antagonistic controls of autophagy
and glycogen accumulation by Snf1p, the yeast homolog of AMP-activated
protein kinase, and the cyclin-dependent kinase Pho85p</article-title>.
<source>Mol. Cell. Biol</source>
<volume>21</volume>,
<fpage>5742</fpage>&#x02013;<lpage>5752</lpage>.<pub-id pub-id-type="pmid">11486014</pub-id></mixed-citation></ref><ref id="R88"><mixed-citation publication-type="journal"><name><surname>Weinberg</surname><given-names>SE</given-names></name>, and <name><surname>Chandel</surname><given-names>NS</given-names></name> (<year>2015</year>). <article-title>Targeting mitochondria metabolism
for cancer therapy</article-title>. <source>Nat. Chem. Biol</source>
<volume>11</volume>, <fpage>9</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">25517383</pub-id></mixed-citation></ref><ref id="R89"><mixed-citation publication-type="journal"><name><surname>Wieckowski</surname><given-names>MR</given-names></name>, <name><surname>Giorgi</surname><given-names>C</given-names></name>, <name><surname>Lebiedzinska</surname><given-names>M</given-names></name>, <name><surname>Duszynski</surname><given-names>J</given-names></name>, and <name><surname>Pinton</surname><given-names>P</given-names></name> (<year>2009</year>). <article-title>Isolation of mitochondria-associated
membranes and mitochondria from animal tissues and cells</article-title>.
<source>Nat. Protoc</source>
<volume>4</volume>,
<fpage>1582</fpage>&#x02013;<lpage>1590</lpage>.<pub-id pub-id-type="pmid">19816421</pub-id></mixed-citation></ref><ref id="R90"><mixed-citation publication-type="journal"><name><surname>Wilson-Zbinden</surname><given-names>C</given-names></name>, <name><surname>dos Santos</surname><given-names>AX</given-names></name>, <name><surname>Stoffel-Studer</surname><given-names>I</given-names></name>, <name><surname>van der Vaart</surname><given-names>A</given-names></name>, <name><surname>Hofmann</surname><given-names>K</given-names></name>, <name><surname>Reggiori</surname><given-names>F</given-names></name>, <name><surname>Riezman</surname><given-names>H</given-names></name>, <name><surname>Kraft</surname><given-names>C</given-names></name>, and <name><surname>Peter</surname><given-names>M</given-names></name> (<year>2015</year>). <article-title>Autophagy competes for a common
phosphatidylethanolamine pool with major cellular PE-consuming pathways in
Saccharomyces cerevisiae</article-title>. <source>Genetics</source>
<volume>199</volume>,
<fpage>475</fpage>&#x02013;<lpage>485</lpage>.<pub-id pub-id-type="pmid">25519895</pub-id></mixed-citation></ref><ref id="R91"><mixed-citation publication-type="journal"><name><surname>Wise</surname><given-names>DR</given-names></name>, and <name><surname>Thompson</surname><given-names>CB</given-names></name> (<year>2010</year>). <article-title>Glutamine addiction: a new
therapeutic target in cancer</article-title>. <source>Trends Biochem.
Sci</source>
<volume>35</volume>,
<fpage>427</fpage>&#x02013;<lpage>433</lpage>.<pub-id pub-id-type="pmid">20570523</pub-id></mixed-citation></ref><ref id="R92"><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Z</given-names></name>, and <name><surname>Klionsky</surname><given-names>DJ</given-names></name> (<year>2010</year>). <article-title>Mammalian autophagy: core molecular
machinery and signaling regulation</article-title>. <source>Curr. Opin. Cell
Biol</source>
<volume>22</volume>,
<fpage>124</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="pmid">20034776</pub-id></mixed-citation></ref><ref id="R93"><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>S</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Contino</surname><given-names>G</given-names></name>, <name><surname>Liesa</surname><given-names>M</given-names></name>, <name><surname>Sahin</surname><given-names>E</given-names></name>, <name><surname>Ying</surname><given-names>H</given-names></name>, <name><surname>Bause</surname><given-names>A</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Stommel</surname><given-names>JM</given-names></name>, <name><surname>Dell&#x02019;antonio</surname><given-names>G</given-names></name>, <etal/> (<year>2011</year>). <article-title>Pancreatic cancers require
autophagy for tumor growth</article-title>. <source>Genes Dev</source>.
<volume>25</volume>,
<fpage>717</fpage>&#x02013;<lpage>729</lpage>.<pub-id pub-id-type="pmid">21406549</pub-id></mixed-citation></ref><ref id="R94"><mixed-citation publication-type="journal"><name><surname>Yoshii</surname><given-names>SR</given-names></name>, <name><surname>Kishi</surname><given-names>C</given-names></name>, <name><surname>Ishihara</surname><given-names>N</given-names></name>, and <name><surname>Mizushima</surname><given-names>N</given-names></name> (<year>2011</year>). <article-title>Parkin mediates proteasome-dependent
protein degradation and rupture of the outer mitochondrial
membrane</article-title>. <source>J. Biol. Chem</source>
<volume>286</volume>,
<fpage>19630</fpage>&#x02013;<lpage>19640</lpage>.<pub-id pub-id-type="pmid">21454557</pub-id></mixed-citation></ref><ref id="R95"><mixed-citation publication-type="journal"><name><surname>Youle</surname><given-names>RJ</given-names></name>, and <name><surname>Narendra</surname><given-names>DP</given-names></name> (<year>2011</year>). <article-title>Mechanisms of
mitophagy</article-title>. <source>Nat. Rev. Mol. Cell Biol</source>
<volume>12</volume>, <fpage>9</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">21179058</pub-id></mixed-citation></ref><ref id="R96"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Zeng</surname><given-names>X</given-names></name>, <name><surname>Ren</surname><given-names>M</given-names></name>, <name><surname>Mao</surname><given-names>X</given-names></name>, and <name><surname>Qiao</surname><given-names>S</given-names></name> (<year>2017</year>). <article-title>Novel metabolic and physiological
functions of branched chain amino acids: a review</article-title>.
<source>J. Anim. Sci. Biotechnol</source>
<volume>8</volume>, <fpage>10</fpage>.<pub-id pub-id-type="pmid">28127425</pub-id></mixed-citation></ref><ref id="R97"><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>X</given-names></name>, <name><surname>Boyer</surname><given-names>L</given-names></name>, <name><surname>Jin</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>Y</given-names></name>, <name><surname>Fan</surname><given-names>W</given-names></name>, <name><surname>Bardy</surname><given-names>C</given-names></name>, <name><surname>Berggren</surname><given-names>T</given-names></name>, <name><surname>Evans</surname><given-names>RM</given-names></name>, <name><surname>Gage</surname><given-names>FH</given-names></name>, and <name><surname>Hunter</surname><given-names>T</given-names></name> (<year>2016</year>). <article-title>Alleviation of neuronal energy
deficiency by mTOR inhibition as a treatment for mitochondria-related
neurodegeneration</article-title>. <source>eLife</source>
<volume>5</volume>, <fpage>e13378</fpage>.<pub-id pub-id-type="pmid">27008180</pub-id></mixed-citation></ref><ref id="R98"><mixed-citation publication-type="journal"><name><surname>Zoncu</surname><given-names>R</given-names></name>, <name><surname>Bar-Peled</surname><given-names>L</given-names></name>, <name><surname>Efeyan</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Sancak</surname><given-names>Y</given-names></name>, and <name><surname>Sabatini</surname><given-names>DM</given-names></name> (<year>2011</year>). <article-title>mTORC1 senses lysosomal amino acids
through an inside-out mechanism that requires the vacuolar
H(+)-ATPase</article-title>. <source>Science</source>
<volume>334</volume>,
<fpage>678</fpage>&#x02013;<lpage>683</lpage>.<pub-id pub-id-type="pmid">22053050</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Phenformin Inhibits Autophagy Induced by mTOR Inhibitors</title><p id="P95">(A and B) Time course of GST-BHMT autophagy assay (A) and plotted ratio
of the BHMT fragment/ GFP-myc (B) in HEK293 cells treated with vehicle (V), 5 nM
RAD001 and 20 nM BEZ235 (RB), or 1 mM phenformin (P<sup>1</sup>).</p><p id="P96">(C) GST-BHMT assay in HEK293 cells treated for 6 hr with 0&#x02013;5 mM
phenformin alone, or in combination with RB.</p><p id="P97">(D and E) LC3-II flux assay (D) and ratio of LC3-II/ACTIN (E) in HEK293
cells treated as indicated.</p><p id="P98">(F and G) Representative confocal images (F) and quantitation of LC3-B
puncta/cell (G) in HEK293T cells. Treatments as in (D) and (E). Scale bar is 10
&#x003bc;m. Data represented as mean &#x000b1; 1 SD.</p></caption><graphic xlink:href="nihms-1505951-f0002"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><title>Phenformin Inhibits Mitophagy Induced by mTOR Inhibitors</title><p id="P99">(A) GST<sub>LSCS</sub>GFP-ActA mitophagy assay in cells treated for 24
hr with V, RB, P<sup>1</sup>, or RBP<sup>1</sup>.</p><p id="P100">(B) Mitochondrial DNA content, as measured by RT-qPCR. Statistics by
one-way ANOVA.</p><p id="P101">(C) Representative confocal images from Mito-Keima expressing cells,
treated for 4 hr.</p><p id="P102">(D) Complex I activity in mitochondria purified from HEK293 cells. 16
hr treatments.</p><p id="P103">**Adjusted p value = 0.0074. Data represented as mean &#x000b1; 1
SD.</p></caption><graphic xlink:href="nihms-1505951-f0003"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><title>Autophagy Is Inhibited by Severe Defects in Mitochondrial Complex I Accessory
Subunits</title><p id="P104">(A) GST-BHMT assay in control and <italic>NDUFS6</italic> or
<italic>NDUFA10</italic> knockout (KO) cells. 6 hr treatments. A numerical
value for the BHMT fragment (frag)/GFP ratio, normalized to RB, is shown.</p><p id="P105">(B) GST-BHMT assay in HEK293 cells treated for 6 hr, with or without 5
mM nicotinamide (NM).</p><p id="P106">(C) GST<sub>LSCS</sub>GFP-ActA mitophagy assay in HEK293T control and
<italic>NDUFA1</italic><sup>KO</sup> cells treated for 20 hr with V, RB,
P<sup>1</sup>, RBP<sup>1</sup>, or 10 &#x003bc;M CCCP (CC).</p></caption><graphic xlink:href="nihms-1505951-f0004"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4.</label><caption><title>Phenformin Suppresses the Initiation, Amplitude, and Duration of
Autophagy</title><p id="P107">(A) GST-BHMT assay in cells treated for 6 hr with V, RB, P<sup>1</sup>,
RBP<sup>1</sup>, with or without 1 mM adenosine.</p><p id="P108">(B) Bar graph of AMP/ATP ratios in HEK293 cells treated with V, RB,
P<sup>1</sup>, RBP<sup>1</sup>, or starved of glucose.</p><p id="P109">(C and D) Immunofluorescence of WIPI2 in HEK293T cells treated for 2
hr. Representative confocal images (C) and quantification of WIPI2 puncta (D).
Scale bar is 10 &#x003bc;m.</p><p id="P110">(E&#x02013;G) GST-BHMT time course assay in cells treated with V, RB, or
RBP<sup>1.5</sup>, as shown by western blotting (E) and graphs of BHMT
frag/GFP ratios (F) and LC3-II/ACTIN ratios (G).</p></caption><graphic xlink:href="nihms-1505951-f0005"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5.</label><caption><title>Glucose Starvation Increases Autophagy and Mitophagy</title><p id="P111">(A and B) GST-BHMT assay time course in cells treated with V or RB, in
media with 25 or 0 mM glucose, as shown by western blotting (A) and graph of
BHMT frag/GFP ratio (B).</p><p id="P112">(C) GST-BHMT assay in cells treated for 24 hr with vehicle or RB in
DMEM with 25 or 0 mM glucose, 25 mM galactose (Gal), or 100 mM trehalose
(Treh).</p><p id="P113">(D) GST<sub>LSCS</sub>GFP-ActA mitophagy assay in cells treated for 24
hr with 25, 5, or 0 mM glucose; 25 mM Gal; or P<sup>1</sup>, without or with
RB.</p></caption><graphic xlink:href="nihms-1505951-f0006"/></fig><fig id="F6" orientation="portrait" position="float"><label>Figure 6.</label><caption><title>Phospholipid Remodeling in Autophagy</title><p id="P114">(A) Levels of PE (18:0/18:1) and PS (18:0/18:1) in HEK293 cells treated
for 24 hr with V, RB, P<sup>1</sup>, or RBP<sup>1</sup>. ****p &#x0003c; 0.0001,
***p = 0.0002. ns = not significant. Data represented as mean &#x000b1; 1 SD.</p><p id="P115">(B) GST-BHMT autophagy assay in cells transfected with non-silencing
siRNA (siNS), siPISD-6, or siPISD-7. Cells were treated for 6 hr.</p><p id="P116">(C) GST-BHMT autophagy assay in cells treated for 6 hr with drugs as
indicated, with 5 mM L-serine and/or 1 mM hydroxylamine as noted.</p><p id="P117">(D) GST-BHMT autophagy assay in cells treated for 6 hr as indicated,
with buffer or mixed composition liposomes.</p></caption><graphic xlink:href="nihms-1505951-f0007"/></fig><fig id="F7" orientation="portrait" position="float"><label>Figure 7.</label><caption><title>Defects in Complex I Prevent the Significant Increase in MAMs that Occurs
with mTOR Inhibitors</title><p id="P118">(A) Proximity ligation assay showing MAMs by confocal microscopy.
HEK293T cells were treated for 4 hr. Scale bar is 10 &#x003bc;m.</p><p id="P119">(B) Scatter plot graph showing quantified MAMs data. ****p &#x0003c;
0.0001. ns = not significant. Data represented as mean &#x000b1; 1 SD.</p><p id="P120">(C) Model of conditions that support or inhibit autophagy. Left: mTOR
inhibitors (RB) induce active autophagy in cells with healthy mitochondria by
increasing MAMs, sites of ATG14 recruitment and phospholipid transport,
supporting mtPE biosynthesis and sustained autophagy. RB autophagy is enhanced
by conditions that increase TCA intermediates, ATP, or phospholipids. Right:
Autophagy is impaired by phenformin or defects in complex I, which prevent the
increase of MAMs induced by mTOR inhibitors, local ATP, and the ATP-dependent
transfer of PS for mtPE biosynthesis.</p></caption><graphic xlink:href="nihms-1505951-f0008"/></fig><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Highlights</title></caption><list list-type="bullet" id="L5"><list-item><p id="P121">Phenformin, metformin, and mitochondrial complex I defects suppress
autophagy</p></list-item><list-item><p id="P122">Defects in glycolysis and OXPHOS have opposing effects on
autophagy</p></list-item><list-item><p id="P123">Autophagy is enhanced by a metabolic shift toward OXPHOS</p></list-item><list-item><p id="P124">Mitochondrial-associated membranes and mitochondrial PE support
autophagy</p></list-item></list></boxed-text></floats-group></article>